| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA3 MYO1D TDRD9 MYO9A MYO9B ACSS1 HSPH1 ACTB PSMC3 ABCA9 DDX1 MYO5C ABCB1 DHX9 LONP1 HELZ ATP6V1C2 DNAH8 DNAH9 DYNC1H1 HSP90AB3P KIF13B MYO19 SMARCAL1 NLRP3 ATP1A4 ATP2A3 | 3.55e-09 | 614 | 233 | 27 | GO:0140657 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP24 DOCK11 MYO9A MYO9B CYTH1 TBC1D2 MCF2 ARHGAP22 PLEKHG1 DLC1 RASGRP3 DENND4B RAB3GAP2 SIPA1L2 RANBP2 RASGRF2 RASA3 KALRN DOCK8 PRR5 ARHGEF12 DEPDC5 SOS1 SOS2 | 6.81e-09 | 507 | 233 | 24 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP24 DOCK11 MYO9A MYO9B CYTH1 TBC1D2 MCF2 ARHGAP22 PLEKHG1 DLC1 RASGRP3 DENND4B RAB3GAP2 SIPA1L2 RANBP2 RASGRF2 RASA3 KALRN DOCK8 PRR5 ARHGEF12 DEPDC5 SOS1 SOS2 | 6.81e-09 | 507 | 233 | 24 | GO:0030695 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 9.04e-08 | 11 | 233 | 5 | GO:0098973 | |
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP24 MYO9A MYO9B TBC1D2 ARHGAP22 DLC1 RASGRP3 RAB3GAP2 SIPA1L2 RANBP2 RASA3 PRR5 ARHGEF12 DEPDC5 SOS1 | 1.07e-06 | 279 | 233 | 15 | GO:0005096 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA3 TDRD9 MYO9B ACTB PSMC3 ABCA9 DDX1 ABCB1 DHX9 LONP1 DNAH8 DNAH9 DYNC1H1 HSP90AB3P KIF13B MYO19 NLRP3 ATP1A4 ATP2A3 | 1.13e-06 | 441 | 233 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | DOCK11 CYTH1 MCF2 PLEKHG1 RASGRP3 DENND4B RAB3GAP2 RASGRF2 KALRN DOCK8 ARHGEF12 SOS1 SOS2 | 3.43e-06 | 231 | 233 | 13 | GO:0005085 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 8.74e-06 | 42 | 233 | 6 | GO:0098918 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.02e-05 | 118 | 233 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 3.23e-05 | 32 | 233 | 5 | GO:0099186 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | ARHGAP24 DOCK11 MYO9A MYO9B CYTH1 TBC1D2 MCF2 BIRC6 ARHGAP22 PLEKHG1 DLC1 RASGRP3 DENND4B RAB3GAP2 SIPA1L2 RANBP2 RASGRF2 RASA3 KALRN DOCK8 OTUB1 PRR5 ARHGEF12 RICTOR OAZ2 SHOC2 NLRP3 RBCK1 CCNF DEPDC5 ATP2A3 PIK3R5 SOS1 SOS2 | 4.89e-05 | 1418 | 233 | 34 | GO:0030234 |
| GeneOntologyMolecularFunction | microfilament motor activity | 7.60e-05 | 38 | 233 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPIRE2 MYO1D TRPM7 MYO9A MYO9B HSPH1 ACTB SYNPO ACTN2 EPB41L4A ADCY8 NME8 MYO5C DRG1 PROM1 EFHC1 DLC1 ALMS1 AGBL1 UTRN FBXW11 KIF13B MYO19 MAP10 PTPRT KIFAP3 IFT88 | 2.12e-04 | 1099 | 233 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | enzyme activator activity | ARHGAP24 MYO9A MYO9B TBC1D2 ARHGAP22 DLC1 RASGRP3 RAB3GAP2 SIPA1L2 RANBP2 RASA3 PRR5 ARHGEF12 RICTOR NLRP3 RBCK1 DEPDC5 ATP2A3 SOS1 | 2.66e-04 | 656 | 233 | 19 | GO:0008047 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | NUGGC ABCA3 TDRD9 MYO9B ACTB PSMC3 ABCA9 DDX1 ABCB1 DHX9 DRG1 LONP1 DNAH8 DNAH9 DYNC1H1 HSP90AB3P KIF13B MYO19 NLRP3 ATP1A4 ATP2A3 | 3.11e-04 | 775 | 233 | 21 | GO:0017111 |
| GeneOntologyMolecularFunction | (1->3)-beta-D-glucan binding | 8.01e-04 | 4 | 233 | 2 | GO:0001872 | |
| GeneOntologyMolecularFunction | DNA/RNA helicase activity | 8.01e-04 | 4 | 233 | 2 | GO:0033677 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | NUGGC ABCA3 TDRD9 MYO9B ACTB PSMC3 ABCA9 DDX1 ABCB1 DHX9 DRG1 LONP1 DNAH8 DNAH9 DYNC1H1 HSP90AB3P KIF13B MYO19 NLRP3 ATP1A4 ATP2A3 | 8.67e-04 | 839 | 233 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | NUGGC ABCA3 TDRD9 MYO9B ACTB PSMC3 ABCA9 DDX1 ABCB1 DHX9 DRG1 LONP1 DNAH8 DNAH9 DYNC1H1 HSP90AB3P KIF13B MYO19 NLRP3 ATP1A4 ATP2A3 | 8.80e-04 | 840 | 233 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | NUGGC ABCA3 TDRD9 MYO9B ACTB PSMC3 ABCA9 DDX1 ABCB1 DHX9 DRG1 LONP1 DNAH8 DNAH9 DYNC1H1 HSP90AB3P KIF13B MYO19 NLRP3 ATP1A4 ATP2A3 | 8.80e-04 | 840 | 233 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.12e-03 | 18 | 233 | 3 | GO:0008569 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGAP24 MYO9A MYO9B CYTH1 MCF2 ARHGAP22 PLEKHG1 DLC1 DENND4B SIPA1L2 RASGRF2 RASA3 KALRN DOCK8 ARHGEF12 SHOC2 SOS1 SOS2 | 4.65e-08 | 333 | 232 | 18 | GO:0051056 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ARHGAP24 DOCK11 MYO9A MYO9B CYTH1 MCF2 ARHGAP22 PLEKHG1 DLC1 RASGRP3 DENND4B SIPA1L2 RASGRF2 RASA3 KALRN DOCK8 ARHGEF12 SHOC2 CDH13 SOS1 SOS2 | 8.31e-07 | 538 | 232 | 21 | GO:0007264 |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 1.80e-05 | 73 | 232 | 7 | GO:0001738 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 2.31e-05 | 31 | 232 | 5 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 4.25e-05 | 35 | 232 | 5 | GO:0099188 | |
| GeneOntologyCellularComponent | outer dynein arm | 6.71e-06 | 12 | 231 | 4 | GO:0036157 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO1D MYO9A MYO9B ACTB ACTG1 SYNPO ACTN2 ADCY8 MYO5C DHX9 POTEE DLC1 FGR FCHSD1 KALRN POTEF MYO19 CASK TRMT10A POTEI | 6.83e-06 | 576 | 231 | 20 | GO:0015629 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 2.49e-05 | 32 | 231 | 5 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 2.49e-05 | 32 | 231 | 5 | GO:0043189 | |
| GeneOntologyCellularComponent | actin filament | 3.66e-05 | 146 | 231 | 9 | GO:0005884 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 4.94e-05 | 19 | 231 | 4 | GO:0098871 | |
| GeneOntologyCellularComponent | TORC2 complex | 1.07e-04 | 9 | 231 | 3 | GO:0031932 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.34e-04 | 45 | 231 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.53e-04 | 25 | 231 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 1.79e-04 | 26 | 231 | 4 | GO:0099571 | |
| GeneOntologyCellularComponent | cytoplasmic region | ODAD1 NME8 EFHC1 DNAH8 DNAH9 DYNC1H1 FBXW11 RSPH4A KIFAP3 IFT88 BBS7 CTNND1 RIMS2 | 1.97e-04 | 360 | 231 | 13 | GO:0099568 |
| GeneOntologyCellularComponent | cell cortex | SPIRE2 MYO1D MYO9B ACTB EXOC3 ACTN2 DLC1 EXOC6B DYNC1H1 FCHSD1 POTEF CTNND1 RIMS2 | 2.64e-04 | 371 | 231 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | TOR complex | 2.72e-04 | 12 | 231 | 3 | GO:0038201 | |
| GeneOntologyCellularComponent | dynein complex | 3.21e-04 | 54 | 231 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | microtubule associated complex | 4.34e-04 | 161 | 231 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | myosin complex | 4.86e-04 | 59 | 231 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | BRPF3 PSMA7 ACTB PSMC3 ACTG1 KLHL41 DDX1 DHX9 CEP170 POTEE RASGRP3 PRAMEF26 FBXW11 POTEF POLR2C PRR5 RICTOR RBCK1 CCNF MTOR DEPDC5 POTEI EIF4G3 | 5.05e-04 | 972 | 231 | 23 | GO:0140535 |
| GeneOntologyCellularComponent | axoneme | 5.12e-04 | 207 | 231 | 9 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 5.30e-04 | 208 | 231 | 9 | GO:0097014 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 6.18e-04 | 94 | 231 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | ODAD1 NME8 EFHC1 DNAH8 DNAH9 DYNC1H1 FBXW11 RSPH4A KIFAP3 IFT88 BBS7 | 8.43e-04 | 317 | 231 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.05e-03 | 104 | 231 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.08e-03 | 230 | 231 | 9 | GO:0019898 | |
| GeneOntologyCellularComponent | piP-body | 1.19e-03 | 5 | 231 | 2 | GO:0071547 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.34e-03 | 109 | 231 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.59e-03 | 153 | 231 | 7 | GO:0097731 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 1.71e-03 | 155 | 231 | 7 | GO:0098685 | |
| GeneOntologyCellularComponent | centrosome | CEP85L BIRC6 DHX9 CEP170 EFHC1 CEP120 ALMS1 PKHD1 DYNC1H1 FBXW11 SLF1 MAP10 CCNF KIFAP3 IFT88 BBS7 ATM PIK3R5 | 2.35e-03 | 770 | 231 | 18 | GO:0005813 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MYO9A MYO9B KRTAP19-4 HSPH1 ACTB ACTG1 ACTN2 CEP170 POTEE EFHC1 DLC1 DNAH8 DNAH9 DYNC1H1 FBXW11 KIF13B POTEF MAP10 KIFAP3 POTEI | 2.42e-03 | 899 | 231 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | dense body | 2.46e-03 | 7 | 231 | 2 | GO:0097433 | |
| Domain | Actin_CS | 1.11e-06 | 16 | 232 | 5 | IPR004001 | |
| Domain | ACTINS_2 | 1.55e-06 | 17 | 232 | 5 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.13e-06 | 18 | 232 | 5 | IPR020902 | |
| Domain | P-loop_NTPase | NUGGC ABCA3 MYO1D TDRD9 MYO9A MYO9B PSMC3 ABCA9 DDX1 AK3 MYO5C ABCB1 DHX9 DRG1 LONP1 SULT2A1 HELZ DNAH8 DNAH9 DYNC1H1 KIF13B NDST1 MYO19 SMARCAL1 NLRP3 CASK PSTK CTPS1 | 2.43e-06 | 848 | 232 | 28 | IPR027417 |
| Domain | ACTINS_ACT_LIKE | 2.86e-06 | 19 | 232 | 5 | PS01132 | |
| Domain | DH_1 | 1.28e-05 | 63 | 232 | 7 | PS00741 | |
| Domain | FATC | 1.86e-05 | 5 | 232 | 3 | PF02260 | |
| Domain | RhoGEF | 2.12e-05 | 68 | 232 | 7 | SM00325 | |
| Domain | RhoGEF | 2.57e-05 | 70 | 232 | 7 | PF00621 | |
| Domain | DH_2 | 2.57e-05 | 70 | 232 | 7 | PS50010 | |
| Domain | - | 2.82e-05 | 71 | 232 | 7 | 1.20.900.10 | |
| Domain | DH-domain | 2.82e-05 | 71 | 232 | 7 | IPR000219 | |
| Domain | PI3/4_kinase_CS | 2.84e-05 | 15 | 232 | 4 | IPR018936 | |
| Domain | PH | ARHGAP24 DOCK11 CYTH1 TBC1D2 MCF2 ARHGAP22 PLEKHG1 RASGRF2 RASA3 KALRN SOS1 SOS2 | 3.08e-05 | 229 | 232 | 12 | PF00169 |
| Domain | FATC_dom | 3.68e-05 | 6 | 232 | 3 | IPR003152 | |
| Domain | FATC | 3.68e-05 | 6 | 232 | 3 | SM01343 | |
| Domain | FAT | 3.68e-05 | 6 | 232 | 3 | PS51189 | |
| Domain | FATC | 3.68e-05 | 6 | 232 | 3 | PS51190 | |
| Domain | PIK_FAT | 3.68e-05 | 6 | 232 | 3 | IPR014009 | |
| Domain | Actin | 3.70e-05 | 31 | 232 | 5 | IPR004000 | |
| Domain | Actin | 3.70e-05 | 31 | 232 | 5 | PF00022 | |
| Domain | ACTIN | 3.70e-05 | 31 | 232 | 5 | SM00268 | |
| Domain | PI3Kc | 3.75e-05 | 16 | 232 | 4 | SM00146 | |
| Domain | - | 3.75e-05 | 16 | 232 | 4 | 1.10.1070.11 | |
| Domain | PH | ARHGAP24 DOCK11 CYTH1 TBC1D2 MCF2 ARHGAP22 PLEKHG1 RASGRF2 RASA3 KALRN ARHGEF12 SOS1 SOS2 | 4.72e-05 | 278 | 232 | 13 | SM00233 |
| Domain | PH_DOMAIN | ARHGAP24 DOCK11 CYTH1 TBC1D2 MCF2 ARHGAP22 PLEKHG1 RASGRF2 RASA3 KALRN ARHGEF12 SOS1 SOS2 | 4.89e-05 | 279 | 232 | 13 | PS50003 |
| Domain | PH_domain | ARHGAP24 DOCK11 CYTH1 TBC1D2 MCF2 ARHGAP22 PLEKHG1 RASGRF2 RASA3 KALRN ARHGEF12 SOS1 SOS2 | 5.08e-05 | 280 | 232 | 13 | IPR001849 |
| Domain | PI3/4_kinase_cat_dom | 6.19e-05 | 18 | 232 | 4 | IPR000403 | |
| Domain | PI3_PI4_kinase | 6.19e-05 | 18 | 232 | 4 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 6.19e-05 | 18 | 232 | 4 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.19e-05 | 18 | 232 | 4 | PS00916 | |
| Domain | PI3_4_KINASE_3 | 6.19e-05 | 18 | 232 | 4 | PS50290 | |
| Domain | ARM-type_fold | SMG1 DOCK11 PIK3C2A HECTD1 AGBL1 DOCK8 RICTOR HEATR1 ARMC1 KIFAP3 MTOR ATM CTNND1 EIF4G3 | 9.24e-05 | 339 | 232 | 14 | IPR016024 |
| Domain | RasGEFN | 9.61e-05 | 20 | 232 | 4 | SM00229 | |
| Domain | DHC_N1 | 1.01e-04 | 8 | 232 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.01e-04 | 8 | 232 | 3 | IPR013594 | |
| Domain | MYOSIN_MOTOR | 1.02e-04 | 38 | 232 | 5 | PS51456 | |
| Domain | Myosin_head_motor_dom | 1.02e-04 | 38 | 232 | 5 | IPR001609 | |
| Domain | Myosin_head | 1.02e-04 | 38 | 232 | 5 | PF00063 | |
| Domain | MYSc | 1.02e-04 | 38 | 232 | 5 | SM00242 | |
| Domain | GDS_CDC24_CS | 1.16e-04 | 39 | 232 | 5 | IPR001331 | |
| Domain | RasGEF_N | 1.18e-04 | 21 | 232 | 4 | PF00618 | |
| Domain | - | ARHGAP24 DOCK11 CYTH1 TBC1D2 MCF2 EPB41L4A ARHGAP22 PLEKHG1 RANBP2 RASGRF2 RASA3 KALRN ARHGEF12 SOS1 SOS2 | 1.18e-04 | 391 | 232 | 15 | 2.30.29.30 |
| Domain | Ras-like_Gua-exchang_fac_N | 1.42e-04 | 22 | 232 | 4 | IPR000651 | |
| Domain | RASGEF_NTER | 1.42e-04 | 22 | 232 | 4 | PS50212 | |
| Domain | ATM/Tel1 | 1.54e-04 | 2 | 232 | 2 | IPR015519 | |
| Domain | - | NUGGC ABCA3 TDRD9 PSMC3 ABCA9 DDX1 AK3 ABCB1 DHX9 DRG1 LONP1 SULT2A1 HELZ DNAH8 DNAH9 DYNC1H1 NDST1 MYO19 SMARCAL1 CASK PSTK CTPS1 | 1.62e-04 | 746 | 232 | 22 | 3.40.50.300 |
| Domain | PH_dom-like | ARHGAP24 DOCK11 CYTH1 TBC1D2 MCF2 EPB41L4A ARHGAP22 PLEKHG1 RANBP2 RASGRF2 RASA3 KALRN ARHGEF12 SOS1 SOS2 | 2.99e-04 | 426 | 232 | 15 | IPR011993 |
| Domain | RASGEF_CAT | 4.32e-04 | 29 | 232 | 4 | PS50009 | |
| Domain | Spectrin_repeat | 4.32e-04 | 29 | 232 | 4 | IPR002017 | |
| Domain | AAA+_ATPase | 4.44e-04 | 144 | 232 | 8 | IPR003593 | |
| Domain | AAA | 4.44e-04 | 144 | 232 | 8 | SM00382 | |
| Domain | RasGEF | 4.93e-04 | 30 | 232 | 4 | PF00617 | |
| Domain | - | 4.93e-04 | 30 | 232 | 4 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 4.93e-04 | 30 | 232 | 4 | IPR001895 | |
| Domain | RasGEF | 4.93e-04 | 30 | 232 | 4 | SM00147 | |
| Domain | Ras_GEF_dom | 4.93e-04 | 30 | 232 | 4 | IPR023578 | |
| Domain | IQ | 5.14e-04 | 81 | 232 | 6 | SM00015 | |
| Domain | ATPase_dyneun-rel_AAA | 6.22e-04 | 14 | 232 | 3 | IPR011704 | |
| Domain | MT | 6.22e-04 | 14 | 232 | 3 | PF12777 | |
| Domain | AAA_8 | 6.22e-04 | 14 | 232 | 3 | PF12780 | |
| Domain | AAA_5 | 6.22e-04 | 14 | 232 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.22e-04 | 14 | 232 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.22e-04 | 14 | 232 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.22e-04 | 14 | 232 | 3 | IPR013602 | |
| Domain | DHC_N2 | 6.22e-04 | 14 | 232 | 3 | PF08393 | |
| Domain | Ras_G-nucl-exch_fac_CS | 6.22e-04 | 14 | 232 | 3 | IPR019804 | |
| Domain | SPEC | 6.35e-04 | 32 | 232 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 6.35e-04 | 32 | 232 | 4 | IPR018159 | |
| Domain | DHC_fam | 7.71e-04 | 15 | 232 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 7.71e-04 | 15 | 232 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.71e-04 | 15 | 232 | 3 | IPR004273 | |
| Domain | Rho_GTPase_activation_prot | 7.99e-04 | 88 | 232 | 6 | IPR008936 | |
| Domain | IQ_motif_EF-hand-BS | 8.99e-04 | 90 | 232 | 6 | IPR000048 | |
| Domain | RhoGAP | 1.03e-03 | 62 | 232 | 5 | SM00324 | |
| Domain | IQ | 1.07e-03 | 93 | 232 | 6 | PS50096 | |
| Domain | RhoGAP | 1.11e-03 | 63 | 232 | 5 | PF00620 | |
| Domain | - | 1.16e-03 | 207 | 232 | 9 | 1.25.40.10 | |
| Domain | RhoGAP_dom | 1.19e-03 | 64 | 232 | 5 | IPR000198 | |
| Domain | - | 1.19e-03 | 64 | 232 | 5 | 1.10.555.10 | |
| Domain | RHOGAP | 1.19e-03 | 64 | 232 | 5 | PS50238 | |
| Domain | LRR_8 | 1.36e-03 | 171 | 232 | 8 | PF13855 | |
| Domain | PKD_2 | 1.50e-03 | 5 | 232 | 2 | IPR003915 | |
| Domain | SapB_2 | 1.50e-03 | 5 | 232 | 2 | PF03489 | |
| Domain | SapB_2 | 1.50e-03 | 5 | 232 | 2 | IPR008138 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.70e-03 | 177 | 232 | 8 | IPR003591 | |
| Domain | LRR_TYP | 1.70e-03 | 177 | 232 | 8 | SM00369 | |
| Domain | ARM-like | SMG1 HECTD1 AGBL1 DOCK8 RICTOR HEATR1 ARMC1 KIFAP3 MTOR CTNND1 | 2.09e-03 | 270 | 232 | 10 | IPR011989 |
| Domain | TIR | 2.13e-03 | 21 | 232 | 3 | SM00255 | |
| Domain | Leu-rich_rpt | 2.15e-03 | 271 | 232 | 10 | IPR001611 | |
| Domain | LON | 2.23e-03 | 6 | 232 | 2 | SM00464 | |
| Domain | DUF3398 | 2.23e-03 | 6 | 232 | 2 | PF11878 | |
| Domain | PIK-rel_kinase_FAT | 2.23e-03 | 6 | 232 | 2 | IPR003151 | |
| Domain | LON_N | 2.23e-03 | 6 | 232 | 2 | PS51787 | |
| Domain | DOCK_C/D_N | 2.23e-03 | 6 | 232 | 2 | IPR021816 | |
| Domain | LON_substr-bd_dom | 2.23e-03 | 6 | 232 | 2 | IPR003111 | |
| Domain | SapB | 2.23e-03 | 6 | 232 | 2 | SM00741 | |
| Domain | LON_substr_bdg | 2.23e-03 | 6 | 232 | 2 | PF02190 | |
| Domain | FAT | 2.23e-03 | 6 | 232 | 2 | PF02259 | |
| Domain | TIR | 2.45e-03 | 22 | 232 | 3 | PF01582 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | ARHGAP24 DOCK11 MYO9B MCF2 ARHGAP22 PLEKHG1 DLC1 RASGRF2 DOCK8 ARHGEF12 | 3.05e-07 | 94 | 179 | 10 | MM15598 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP24 DOCK11 MYO9B MCF2 ARHGAP22 PLEKHG1 DLC1 RASGRF2 KALRN DOCK8 SOS1 SOS2 | 2.36e-06 | 175 | 179 | 12 | MM15599 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP24 DOCK11 MYO9B MCF2 ARHGAP22 PLEKHG1 DLC1 RASGRF2 KALRN DOCK8 SOS1 SOS2 | 3.98e-06 | 184 | 179 | 12 | M41809 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP24 DOCK11 MYO9A MYO9B ACTB ACTG1 MCF2 ARHGAP22 PLEKHG1 POTEE DLC1 DYNC1H1 H2AB1 RANBP2 NUP107 RASGRF2 KALRN DOCK8 MYO19 ARHGEF12 SLITRK5 NUP133 SOS1 SOS2 | 1.40e-05 | 720 | 179 | 24 | M41838 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP24 DOCK11 MYO9A MYO9B ACTB ACTG1 MCF2 ARHGAP22 PLEKHG1 POTEE DLC1 RASGRF2 KALRN DOCK8 ARHGEF12 SLITRK5 SOS1 SOS2 | 1.71e-05 | 450 | 179 | 18 | M27078 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP24 DOCK11 MYO9A MYO9B ACTB ACTG1 MCF2 ARHGAP22 PLEKHG1 DLC1 DYNC1H1 RANBP2 NUP107 RASGRF2 KALRN DOCK8 MYO19 ARHGEF12 SLITRK5 NUP133 SOS1 SOS2 | 2.55e-05 | 649 | 179 | 22 | MM15690 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | ARHGAP24 DOCK11 MYO9B MCF2 ARHGAP22 PLEKHG1 DLC1 RASGRF2 DOCK8 ARHGEF12 | 2.84e-05 | 155 | 179 | 10 | M41808 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP24 DOCK11 MYO9A MYO9B ACTB ACTG1 MCF2 ARHGAP22 PLEKHG1 DLC1 RASGRF2 KALRN DOCK8 ARHGEF12 SLITRK5 SOS1 SOS2 | 4.45e-05 | 439 | 179 | 17 | MM15595 |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 4.83e-05 | 52 | 179 | 6 | MM14743 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | PRPF31 SAP18 DHX9 NUP210 PRPF19 PPIE RANBP2 NUP107 POLR2C THOC2 SRRT NUP133 CSTF3 | 6.67e-05 | 283 | 179 | 13 | M13087 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | ARHGAP24 MYO9A MYO9B MCF2 ARHGAP22 DLC1 RASGRF2 KALRN ARHGEF12 | 8.24e-05 | 142 | 179 | 9 | MM15576 |
| Pathway | REACTOME_REGULATION_OF_TP53_DEGRADATION | 8.55e-05 | 36 | 179 | 5 | MM15339 | |
| Pathway | REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION | 9.79e-05 | 37 | 179 | 5 | M27641 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 9.94e-05 | 59 | 179 | 6 | M11215 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | ARHGAP24 MYO9A MYO9B MCF2 ARHGAP22 DLC1 RASGRF2 KALRN ARHGEF12 | 1.19e-04 | 149 | 179 | 9 | M41805 |
| Pathway | REACTOME_METABOLISM_OF_RNA | RPL23A SMG1 PRPF31 SAP18 PSMA7 PSMC3 DDX1 WDR43 DHX9 NUP210 PRPF19 PPIE MTO1 RANBP2 NUP107 POLR2C HEATR1 THOC2 SRRT TRMT10A NUP133 CSTF3 | 1.29e-04 | 724 | 179 | 22 | M16843 |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.43e-04 | 40 | 179 | 5 | MM15060 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 2.19e-04 | 24 | 179 | 4 | M11190 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 2.27e-04 | 44 | 179 | 5 | M109 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 2.58e-04 | 70 | 179 | 6 | MM14824 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.98e-04 | 101 | 179 | 7 | M27253 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 3.43e-04 | 48 | 179 | 5 | MM15069 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 3.51e-04 | 27 | 179 | 4 | M27422 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.96e-04 | 139 | 179 | 8 | M715 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 4.04e-04 | 76 | 179 | 6 | M19832 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 4.33e-04 | 77 | 179 | 6 | MM15044 | |
| Pathway | REACTOME_TRNA_PROCESSING | 5.30e-04 | 111 | 179 | 7 | M27684 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 5.32e-04 | 80 | 179 | 6 | M800 | |
| Pathway | PID_RAS_PATHWAY | 5.32e-04 | 30 | 179 | 4 | M269 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 5.32e-04 | 30 | 179 | 4 | MM15170 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 5.32e-04 | 30 | 179 | 4 | M47752 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 6.07e-04 | 82 | 179 | 6 | M27250 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 6.85e-04 | 32 | 179 | 4 | M29579 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 7.35e-04 | 85 | 179 | 6 | MM14746 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 7.71e-04 | 33 | 179 | 4 | M27016 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47475 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 8.30e-04 | 58 | 179 | 5 | M11980 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | PRPF31 DHX9 NUP210 PRPF19 RANBP2 NUP107 POLR2C THOC2 SRRT NUP133 CSTF3 | 8.31e-04 | 277 | 179 | 11 | MM15414 |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 8.66e-04 | 34 | 179 | 4 | M27041 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 8.98e-04 | 59 | 179 | 5 | M27606 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL23A PRPF31 MYO1D MYO9B GART ACTG1 EXOC3 DDX1 WDR43 MYO5C ABCB1 DHX9 DRG1 CEP170 LONP1 STXBP2 UBR5 NUP210 PRPF19 FKBP8 UTRN DYNC1H1 RANBP2 NUP107 HEATR1 THOC2 CNNM3 SRRT BBS7 NUP133 CSTF3 CTNND1 | 7.43e-13 | 1024 | 236 | 32 | 24711643 |
| Pubmed | PDXDC1 RPL23A HSPH1 GART ACTB PSMC3 DDX1 DHX9 LONP1 NUP210 USP7 PRPF19 FKBP8 HECTD1 DYNC1H1 RANBP2 COPZ1 NUP107 HEATR1 THOC2 USP10 MTOR NUP133 CSTF3 CTPS1 | 2.38e-12 | 638 | 236 | 25 | 33239621 | |
| Pubmed | RPL23A MYO1D GART PSMC3 BIRC6 WDR43 CEP170 LONP1 UBR5 NUP210 USP7 HELZ HECTD1 UTRN DYNC1H1 RANBP2 NUP107 HEATR1 THOC2 MTOR NUP133 ATM EIF4G3 | 1.55e-10 | 653 | 236 | 23 | 22586326 | |
| Pubmed | PDXDC1 ACTB FANCD2 CEP170 NFATC1 NUP210 VPS13A FKBP8 MTO1 SIPA1L2 RANBP2 COPZ1 NUP107 MYO19 POLR2C RICTOR HEATR1 MTOR BBS7 NUP133 TMEM131 CTNND1 | 2.24e-10 | 606 | 236 | 22 | 36538041 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | MYO9A MYO9B HSPH1 PSMA7 PSMC3 DDX1 MYO5C FANCD2 LONP1 DYNC1H1 RANBP2 SHOC2 AASS NUP133 | 2.34e-10 | 211 | 236 | 14 | 17314511 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PRPF31 SPIRE2 TRPM7 DOCK11 MYO9A CEP85L DDX1 CEP170 PLEKHG1 DLC1 ALMS1 PIK3C2A RAB3GAP2 HELZ SIPA1L2 HECTD1 UTRN KIF13B POTEF PRR5 RICTOR SRRT MTOR AASS CTNND1 EIF4G3 | 2.57e-10 | 861 | 236 | 26 | 36931259 |
| Pubmed | MYO1D ACTB PSMC3 ACTG1 EXOC3 BIRC6 FANCD2 LONP1 NUP210 VPS13A USP7 HELZ PRPF19 FKBP8 UTRN FBXW11 RANBP2 NUP107 POLR2C RICTOR SHOC2 RBM20 PTPRT CASK CNNM3 NUP133 CSTF3 CTNND1 | 8.10e-10 | 1049 | 236 | 28 | 27880917 | |
| Pubmed | SAP18 GART ACTB PSMC3 ACTG1 DDX1 WDR43 DHX9 POTEE PIK3C2A USP7 PRPF19 RANBP2 NUP107 HEATR1 THOC2 CASK SRRT USP10 NUP133 CSTF3 CTNND1 | 1.10e-09 | 660 | 236 | 22 | 32780723 | |
| Pubmed | ACTB ACTG1 DHX9 PIK3C2A NUP210 PKHD1 RANBP2 POTEF HEATR1 THOC2 SRRT TRIM40 EIF4G3 | 1.51e-09 | 202 | 236 | 13 | 24639526 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL23A PRPF31 MYO1D HSPH1 PSMA7 GART PSMC3 ACTG1 DDX1 WDR43 DHX9 DRG1 FANCD2 LONP1 RAB3GAP2 NUP210 USP7 PRPF19 DYNC1H1 RANBP2 NUP107 OTUB1 HEATR1 THOC2 SRRT USP10 MTOR NUP133 CSTF3 ATM CTNND1 CTPS1 | 3.19e-09 | 1425 | 236 | 32 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL23A PRPF31 MYO9A MYO9B HSPH1 PSMA7 GART ACTB PSMC3 EXOC3 BIRC6 DDX1 DHX9 LONP1 PIK3C2A UBR5 USP7 PRPF19 UTRN DYNC1H1 RANBP2 NUP107 RASA3 MYO19 POLR2C RICTOR HEATR1 SRRT NUP133 CTNND1 CTPS1 | 3.61e-09 | 1353 | 236 | 31 | 29467282 |
| Pubmed | RPL23A EFCAB5 SMG1 MYO1D HSPH1 PSMA7 ACTB ACTG1 SYNPO ACTN2 DDX1 ABCB1 POTEE STXBP2 EFCAB12 LMLN VPS13A PKHD1 PRPF19 SIPA1L2 DNAH8 KIF13B RANBP2 POTEF HEATR1 IFT88 ATM POTEI ATP1A4 EIF4G3 RIMS2 ATP2A3 | 4.23e-09 | 1442 | 236 | 32 | 35575683 | |
| Pubmed | ARHGAP24 DOCK11 MYO9A SAP18 PSMA7 GART MCF2 CEP170 ARHGAP22 PLEKHG1 POTEE LONP1 DLC1 USP7 PPIE UTRN RASGRF2 DOCK8 ARHGEF12 HEATR1 CASK SRRT CTNND1 SOS1 SOS2 | 4.48e-09 | 916 | 236 | 25 | 32203420 | |
| Pubmed | HSPH1 PSMA7 GART PSMC3 BIRC6 DRG1 CEP170 LONP1 UBR5 RAB3GAP2 HECTD1 DYNC1H1 RANBP2 NUP107 THOC2 SRRT NUP133 CTNND1 CTPS1 | 5.53e-09 | 534 | 236 | 19 | 35032548 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PDXDC1 RPL23A HSPH1 PSMA7 GART ACTB PSMC3 ACTG1 TTC4 BIRC6 DDX1 DHX9 DRG1 UBR5 NUP210 USP7 PRPF19 FKBP8 HECTD1 DYNC1H1 RANBP2 NUP107 POLR2C THOC2 USP10 AASS NUP133 CTNND1 CTPS1 | 1.04e-08 | 1257 | 236 | 29 | 37317656 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RPL23A SMG1 DOCK11 DHX9 DRG1 CEP170 UBR5 NUP210 HECTD1 RANBP2 NUP107 POLR2C RICTOR SRRT USP10 NUP133 CTNND1 | 1.09e-08 | 440 | 236 | 17 | 34244565 |
| Pubmed | DOCK11 PSMC3 BIRC6 CEP170 PLEKHG1 LONP1 ALMS1 PIK3C2A UBR5 HELZ SIPA1L2 HECTD1 UTRN DOCK8 RICTOR THOC2 USP10 | 1.33e-08 | 446 | 236 | 17 | 24255178 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | SAP18 HSPH1 PSMA7 PSMC3 TTC4 BIRC6 DRG1 FANCD2 UBR5 USP7 FKBP8 HECTD1 DYNC1H1 RANBP2 NUP107 POLR2C HEATR1 NUP133 CTPS1 | 1.62e-08 | 571 | 236 | 19 | 37167062 |
| Pubmed | HEXB TRPM7 CEP85L LONRF1 CYTH1 HSPH1 ACTB SYNPO STAT6 ADAMTS9 USP7 WDR17 HECTD1 UTRN DYNC1H1 FBXW11 NDST1 KALRN POLR2C SIM2 TRIM52 RBCK1 CASK IFT88 TMEM131 ATM EIF4G3 SOS1 SOS2 | 1.68e-08 | 1285 | 236 | 29 | 35914814 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MYO1D MYO9A MYO9B EXOC3 TTC4 STAT2 DDX1 POTEE ALMS1 NFATC1 UBR5 USP7 HELZ SIPA1L2 KIF13B NUP107 POLR2C RBM20 POTEI | 2.57e-08 | 588 | 236 | 19 | 38580884 |
| Pubmed | PDXDC1 RPL23A PRPF31 PSMA7 GART PSMC3 BIRC6 DHX9 FANCD2 UBR5 NUP210 VPS13A FKBP8 RANBP2 MMS22L NUP107 HEATR1 MTOR NUP133 CTPS1 | 2.91e-08 | 657 | 236 | 20 | 36180527 | |
| Pubmed | TRPM7 SAP18 HSPH1 PSMA7 EXOC3 DHX9 DRG1 PLEKHG1 PIK3C2A UBR5 RAB3GAP2 NUP210 VPS13A PRPF19 PPIE FKBP8 SIPA1L2 NUP107 OTUB1 RICTOR HEATR1 ARMC1 CASK CNNM3 USP10 BBS7 NUP133 TMEM131 ATM CTNND1 EIF4G3 | 3.16e-08 | 1487 | 236 | 31 | 33957083 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 3.92e-08 | 15 | 236 | 5 | 16824795 | |
| Pubmed | MYO1D GART ACTB DDX1 WDR43 ABCB1 DHX9 USP7 PRPF19 DYNC1H1 RANBP2 NUP107 OTUB1 HEATR1 CASK NUP133 CTNND1 | 4.35e-08 | 484 | 236 | 17 | 31995728 | |
| Pubmed | HEXB RPL23A MYO1D MYO9A HSPH1 PSMA7 ACTB PSMC3 ACTG1 SYNPO ACTN2 DDX1 DHX9 CEP170 LONP1 SLC24A2 USP7 PRPF19 SIPA1L2 UTRN DYNC1H1 KALRN DOCK8 ARHGEF12 ADGRL1 CASK SRRT USP10 CTNND1 EIF4G3 | 4.76e-08 | 1431 | 236 | 30 | 37142655 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDXDC1 RPL23A MYO1D SAP18 PSMA7 GART PSMC3 TTC4 DHX9 UBR5 RASGRP3 RAB3GAP2 USP7 PRPF19 DYNC1H1 FBXW11 RANBP2 MMS22L RASGRF2 OAZ2 HEATR1 CNNM3 SRRT NUP133 CSTF3 CTPS1 EIF4G3 ATP2A3 | 6.18e-08 | 1284 | 236 | 28 | 17353931 |
| Pubmed | RPL23A SMG1 MYOG PSMC3 KLHL41 ACTN2 BIRC6 CEP170 ALMS1 PIK3C2A ADAMTS9 UTRN RANBP2 RASGRF2 KALRN LAMA2 NUP133 | 6.36e-08 | 497 | 236 | 17 | 23414517 | |
| Pubmed | EXOC3 UBR5 USP7 UTRN SMARCAL1 OTUB1 RICTOR USP10 MTOR DEPDC5 | 7.21e-08 | 147 | 236 | 10 | 29576527 | |
| Pubmed | PDXDC1 CAAP1 SAP18 ACTB TTC4 WDR43 UBR5 RAB3GAP2 NUP107 HEATR1 USP10 MTOR CTNND1 | 1.03e-07 | 288 | 236 | 13 | 23383273 | |
| Pubmed | PDXDC1 RPL23A SAP18 ACTB PSMC3 ACTG1 PLIN2 DHX9 DRG1 POTEE LONP1 USP7 PRPF19 UTRN DYNC1H1 RANBP2 HEATR1 SRRT USP10 CTNND1 | 1.05e-07 | 711 | 236 | 20 | 33022573 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PRPF31 PSMA7 PSMC3 EXOC3 NME8 DDX1 DHX9 DRG1 CEP170 LONP1 EFHC1 CEP120 EXOC6B HELZ DYNC1H1 HSP90AB3P KIF13B COPZ1 NUP107 MYO19 OTUB1 HEATR1 SHOC2 KIFAP3 IFT88 MTOR BBS7 NUP133 | 1.11e-07 | 1321 | 236 | 28 | 27173435 |
| Pubmed | RPL23A MYO1D MYO9B SAP18 HSPH1 GART PSMC3 ACTG1 DDX1 DHX9 LONP1 PIK3C2A USP7 PRPF19 PPIE HECTD1 DYNC1H1 FBXW11 RANBP2 COPZ1 NUP107 SIM2 THOC2 SRRT USP10 CTNND1 CDH3 | 1.25e-07 | 1247 | 236 | 27 | 27684187 | |
| Pubmed | HEXB MYO9B ACTB PSMC3 ACTG1 BIRC6 DDX1 DHX9 DRG1 LONP1 PIK3C2A UBR5 NUP210 HELZ PRPF19 FKBP8 DYNC1H1 RANBP2 NUP107 DOCK8 HEATR1 CNNM3 MTOR NUP133 CTPS1 SLC37A4 | 1.28e-07 | 1168 | 236 | 26 | 19946888 | |
| Pubmed | RPL23A MYO1D SAP18 HSPH1 PSMA7 GART ACTB PSMC3 EXOC3 TTC4 DDX1 AK3 DHX9 DRG1 FANCD2 LONP1 UBR5 USP7 PRPF19 PPIE HECTD1 HSP90AB3P RANBP2 POLR2C IFT88 CSTF3 CTNND1 CTPS1 | 1.38e-07 | 1335 | 236 | 28 | 29229926 | |
| Pubmed | SMG1 DYM HSPH1 PSMA7 PSMC3 SYNPO DDX1 FANCD2 CEP170 LONP1 PIK3C2A UBR5 NUP210 USP7 PRPF19 FKBP8 DYNC1H1 FBXW11 RANBP2 MYO19 OTUB1 HEATR1 THOC2 USP10 MTOR AASS NUP133 ATM CTPS1 | 1.89e-07 | 1440 | 236 | 29 | 30833792 | |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 2.11e-07 | 38 | 236 | 6 | 11756498 | |
| Pubmed | 2.48e-07 | 93 | 236 | 8 | 22079093 | ||
| Pubmed | ACSS1 HSPH1 BIRC6 LAPTM5 CEP170 FAT2 ALMS1 ADAMTS9 RASGRP3 NUP210 HECTD1 KIF13B RICTOR ZBTB34 SLITRK5 SV2C | 3.17e-07 | 493 | 236 | 16 | 15368895 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | RPL23A HSPH1 DDX1 DHX9 DRG1 CEP170 USP7 PRPF19 FBXW11 RANBP2 THOC2 | 3.18e-07 | 217 | 236 | 11 | 31685992 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KBTBD3 DYM ZBTB20 MYO9A SYNPO CEP170 EXD3 NFATC1 LMLN NUP210 EXOC6B PPIE HECTD1 UTRN FBXW11 FUT10 RASA3 PRR5 LMBR1 ADGRL1 TECTA CASK TATDN3 USP10 TMEM98 CSTF3 CTNND1 EIF4G3 SOS2 | 3.76e-07 | 1489 | 236 | 29 | 28611215 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRPF31 PSMC3 BIRC6 DHX9 FANCD2 STXBP2 UBR5 RAB3GAP2 DNAH8 DYNC1H1 KIF13B RANBP2 COPZ1 HEATR1 MTOR NUP133 CTPS1 EIF4G3 ATP2A3 | 4.13e-07 | 704 | 236 | 19 | 29955894 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDXDC1 RPL23A MYO1D TRPM7 ACSS1 PSMA7 PSMC3 TTC4 BIRC6 WDR43 AK3 DHX9 FANCD2 POTEE LONP1 ALMS1 PIK3C2A RAB3GAP2 VPS13A FKBP8 MTO1 NUP107 MYO19 HEATR1 RBM20 CASK AASS NUP133 TMEM131 | 4.13e-07 | 1496 | 236 | 29 | 32877691 |
| Pubmed | 4.53e-07 | 43 | 236 | 6 | 12376548 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | RPL23A SMG1 PRPF31 TDRD9 ACTB DHX9 CEP170 LONP1 FAT1 PIK3C2A UBR5 HELZ PRPF19 SIPA1L2 HECTD1 CASK CTNND1 CTPS1 | 4.55e-07 | 639 | 236 | 18 | 23443559 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL23A PRPF31 MYO1D SAP18 HSPH1 GART ACTB SYNPO DDX1 WDR43 DHX9 DRG1 CEP170 NUP210 USP7 PRPF19 PPIE DYNC1H1 POLR2C HEATR1 THOC2 SRRT USP10 NUP133 CTNND1 CTPS1 | 5.18e-07 | 1257 | 236 | 26 | 36526897 |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 6.57e-07 | 11 | 236 | 4 | 20427287 | |
| Pubmed | RPL23A HSPH1 GART ACTB PSMC3 AK3 DHX9 FANCD2 NUP210 DYNC1H1 RANBP2 USP10 NUP133 CTNND1 CTPS1 | 7.63e-07 | 463 | 236 | 15 | 34901782 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | RPL23A HSPH1 PSMC3 ACTG1 TTC4 DHX9 USP7 HELZ PRPF19 FKBP8 DYNC1H1 HSP90AB3P RANBP2 | 7.75e-07 | 344 | 236 | 13 | 36282215 |
| Pubmed | RPL23A EFCAB5 HSPH1 GART ACTB ACTG1 DDX1 DHX9 DRG1 CEP170 LONP1 USP7 PRPF19 DYNC1H1 FBXW11 THOC2 CASK KIFAP3 SRRT CTPS1 | 7.97e-07 | 809 | 236 | 20 | 32129710 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DOCK11 HSPH1 TBC1D2 BIRC6 DHX9 POTEE EDAR ADAMTS9 DENND4B VPS13A PKHD1 UTRN DYNC1H1 GP1BA TICRR MYO19 IGDCC3 ATM CTPS1 | 8.02e-07 | 736 | 236 | 19 | 29676528 |
| Pubmed | RPL23A MYO9B GART EXOC3 DDX1 DHX9 DRG1 CEP170 LONP1 PRPF19 DYNC1H1 COPZ1 NUP107 OTUB1 RICTOR USP10 CTNND1 | 9.05e-07 | 601 | 236 | 17 | 33658012 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPL23A PRPF31 CAAP1 SAP18 CYTH1 ACTB DDX1 DHX9 DRG1 CEP170 USP7 PRPF19 SIPA1L2 DYNC1H1 RANBP2 KALRN POLR2C THOC2 CASK SRRT CSTF3 ATM PIK3R5 | 1.55e-06 | 1082 | 236 | 23 | 38697112 |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | TBC1D2 EXOC3 SYNPO BIRC6 WDR43 DRG1 LONP1 HELZ ATP6V1C2 SRRT ZFHX4 SLITRK5 ATP2A3 SOS1 | 1.74e-06 | 431 | 236 | 14 | 33660365 |
| Pubmed | HEXB CAAP1 MYO1D SAP18 HSPH1 GART PSMC3 TTC4 DDX1 LONP1 PRPF19 DYNC1H1 COPZ1 NUP107 POLR2C OTUB1 SRRT CSTF3 CTPS1 | 2.10e-06 | 786 | 236 | 19 | 29128334 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDXDC1 HSPH1 PSMC3 DDX1 DRG1 FANCD2 UBR5 RAB3GAP2 NUP210 FKBP8 HECTD1 DYNC1H1 RANBP2 NUP107 LMBR1 HEATR1 CNNM3 MTOR NUP133 CSTF3 EIF4G3 | 2.16e-06 | 942 | 236 | 21 | 31073040 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDXDC1 HEXB RPL23A HSPH1 PSMA7 GART TBC1D2 PSMC3 ACTG1 TTC4 BIRC6 DDX1 STAT6 DHX9 FANCD2 RAB3GAP2 USP7 PRPF19 HECTD1 DYNC1H1 COPZ1 POLR2C SRRT TRMT10A MTOR NUP133 CTPS1 | 2.43e-06 | 1455 | 236 | 27 | 22863883 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | PDXDC1 DYM MYO1D HSPH1 PSMA7 PSMC3 ACTN2 UBR5 RAB3GAP2 NUP210 FKBP8 DYNC1H1 RANBP2 MTOR CTPS1 ATP2A3 CDH3 | 2.45e-06 | 647 | 236 | 17 | 26618866 |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 2.60e-06 | 89 | 236 | 7 | 22446626 | |
| Pubmed | RPL23A PRPF31 PSMA7 ACTB ACTG1 SYNPO DHX9 POTEE PRPF19 HECTD1 POTEF PIWIL4 TECTA LRRC37B ATP2A3 | 2.69e-06 | 513 | 236 | 15 | 25798074 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ACTB PSMC3 DDX1 DHX9 DRG1 FANCD2 PRPF19 DYNC1H1 RANBP2 NUP107 DOCK8 SHOC2 USP10 CSTF3 ATM CTNND1 | 2.75e-06 | 582 | 236 | 16 | 20467437 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | PRPF31 HSPH1 GART DDX1 DHX9 ARHGAP22 NFATC1 USP7 PRPF19 RANBP2 NUP107 SIM2 THOC2 SRRT ZFHX4 CTPS1 | 2.81e-06 | 583 | 236 | 16 | 29844126 |
| Pubmed | Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease. | 3.05e-06 | 5 | 236 | 3 | 29275858 | |
| Pubmed | USP10 regulates p53 localization and stability by deubiquitinating p53. | 3.05e-06 | 5 | 236 | 3 | 20096447 | |
| Pubmed | SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation. | 3.18e-06 | 130 | 236 | 8 | 32905556 | |
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 3.38e-06 | 60 | 236 | 6 | 12787561 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | RPL23A SAP18 ACTB DHX9 STXBP2 DNAH9 DYNC1H1 TRHDE RASA3 DOCK8 CSTF3 SOS1 | 3.38e-06 | 333 | 236 | 12 | 32665550 |
| Pubmed | 3.53e-06 | 16 | 236 | 4 | 35980206 | ||
| Pubmed | DOCK11 HSPH1 PSMA7 PSMC3 DDX1 UBR5 USP7 PRPF19 FKBP8 DYNC1H1 RANBP2 CTNND1 CTPS1 | 3.96e-06 | 399 | 236 | 13 | 37536630 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HEXB RPL23A PRPF31 HSPH1 PSMA7 GART ACTB PSMC3 DDX1 DHX9 DRG1 CEP170 STXBP2 UBR5 RAB3GAP2 USP7 PRPF19 DYNC1H1 RANBP2 COPZ1 OTUB1 CTPS1 EIF4G3 | 4.19e-06 | 1149 | 236 | 23 | 35446349 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | HEXB MYO1D PSMA7 ACTB BDH2 ACTG1 ACTN2 MYO5C ABCB1 POTEE PROM1 STXBP2 AFM DYNC1H1 GP1BA HSP90AB3P TRHDE ROBO4 POTEF OTUB1 POTEI CDH13 | 4.49e-06 | 1070 | 236 | 22 | 23533145 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPL23A PRPF31 HSPH1 PSMA7 GART ACTB PSMC3 ACTG1 BIRC6 DDX1 DHX9 DRG1 CEP170 LONP1 UBR5 USP7 PRPF19 PPIE HECTD1 DYNC1H1 RANBP2 POLR2C SRRT USP10 CTNND1 CTPS1 | 4.51e-06 | 1415 | 236 | 26 | 28515276 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL23A PRPF31 MYO9B BIRC6 DDX1 WDR43 DHX9 DRG1 CEP170 PRPF19 HECTD1 TICRR HEATR1 THOC2 SRRT USP10 NUP133 EIF4G3 | 5.11e-06 | 759 | 236 | 18 | 35915203 |
| Pubmed | 5.68e-06 | 100 | 236 | 7 | 10048485 | ||
| Pubmed | Mutation of ARHGAP9 in patients with coronary spastic angina. | 5.77e-06 | 38 | 236 | 5 | 19911011 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 30865892 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 29567957 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 22500797 | ||
| Pubmed | PDXDC1 TDRD15 TRPM7 BIRC6 DHX9 FAT1 UBR5 VPS13A FKBP8 DYNC1H1 COPZ1 NUP107 RICTOR CASK CNNM3 SLITRK5 CTNND1 EIF4G3 | 7.03e-06 | 777 | 236 | 18 | 35844135 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | SAP18 PSMA7 GART DRG1 HELZ PRPF19 DYNC1H1 POLR2C CASK SRRT MTOR RIMS2 | 7.04e-06 | 358 | 236 | 12 | 32460013 |
| Pubmed | PDXDC1 HEXB EXOC3 DENND4B SIPA1L2 UTRN RASA3 PRR5 ADGRL1 RICTOR CASK CNNM3 CTNND1 | 7.06e-06 | 421 | 236 | 13 | 36976175 | |
| Pubmed | PDXDC1 HEXB RPL23A PRPF31 HSPH1 GART ACTB PSMC3 ACTG1 BIRC6 DHX9 DRG1 CEP170 FAT1 UBR5 NUP210 PRPF19 HECTD1 DYNC1H1 POLR2C OTUB1 SHOC2 USP10 CTPS1 | 9.57e-06 | 1297 | 236 | 24 | 33545068 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | MYO9A HSPH1 ACTB PSMC3 FANCD2 LONP1 UBR5 PRPF19 UTRN DYNC1H1 FBXW11 RASA3 CNNM3 POTEI CTPS1 | 1.01e-05 | 573 | 236 | 15 | 28330616 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.09e-05 | 202 | 236 | 9 | 33005030 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | PRPF31 HSPH1 PSMA7 GART ACTB PSMC3 DDX1 DHX9 DRG1 PRPF19 USP10 | 1.20e-05 | 316 | 236 | 11 | 31665637 |
| Pubmed | ACSS1 EXOC3 BIRC6 LONP1 UBR5 VPS13A HECTD1 UTRN POLR2C RICTOR ARMC1 AASS POTEI EIF4G3 | 1.32e-05 | 515 | 236 | 14 | 31617661 | |
| Pubmed | BRPF3 TRPM7 HSPH1 ACTG1 TTC4 BIRC6 WDR43 FANCD2 UBR5 RAB3GAP2 USP7 HELZ MTO1 HECTD1 SLF1 SMARCAL1 SLC35B3 LMBR1 RICTOR HEATR1 CNNM3 USP10 DEPDC5 SOS1 | 1.39e-05 | 1327 | 236 | 24 | 32694731 | |
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 12724322 | ||
| Pubmed | Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. | 1.68e-05 | 8 | 236 | 3 | 17991864 | |
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 15268862 | ||
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 14565974 | ||
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 20100933 | ||
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 20810650 | ||
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 24740015 | ||
| Pubmed | OTUB1 modulates c-IAP1 stability to regulate signalling pathways. | 1.97e-05 | 24 | 236 | 4 | 23524849 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | GART PSMC3 DDX1 DRG1 LONP1 STXBP2 USP7 PRPF19 RANBP2 NUP107 SRRT AASS NUP133 CTNND1 CTPS1 | 1.98e-05 | 607 | 236 | 15 | 39147351 |
| Pubmed | RPL23A HSPH1 PSMA7 ACTB PSMC3 STAT2 DDX1 DHX9 UBR5 UTRN DYNC1H1 HSP90AB3P POTEF MTOR | 2.14e-05 | 538 | 236 | 14 | 28524877 | |
| Pubmed | PRPF31 SAP18 PSMA7 DDX1 DHX9 FANCD2 LONP1 UBR5 USP7 RANBP2 SMARCAL1 POLR2C OTUB1 THOC2 SRRT USP10 NUP133 CSTF3 ATM CTNND1 | 2.24e-05 | 1014 | 236 | 20 | 32416067 | |
| Pubmed | 2.34e-05 | 25 | 236 | 4 | 10601273 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPH1 GART WDR43 CEP170 ALMS1 USP7 HELZ PRPF19 SIPA1L2 UTRN RANBP2 NUP107 HEATR1 THOC2 USP10 NUP133 CTNND1 CTPS1 EIF4G3 | 2.38e-05 | 934 | 236 | 19 | 33916271 |
| Pubmed | 2.51e-05 | 9 | 236 | 3 | 24091496 | ||
| Interaction | LRRFIP2 interactions | HSPH1 ACTB PSMC3 ACTG1 SYNPO MYO5C FANCD2 PPIE HECTD1 MYO19 CCNF EIF4G3 | 1.19e-08 | 117 | 234 | 12 | int:LRRFIP2 |
| Interaction | KIF23 interactions | RPL23A MYO9B SAP18 GART PSMC3 ZNF200 BIRC6 DDX1 WDR43 MYO5C DHX9 DRG1 CEP170 POTEE LONP1 ALMS1 UBR5 USP7 HECTD1 DYNC1H1 HSP90AB3P KIF13B COPZ1 LAMA2 XDH RICTOR HEATR1 THOC2 CCNF SRRT CTPS1 EIF4G3 | 3.90e-07 | 1031 | 234 | 32 | int:KIF23 |
| Interaction | CDC42 interactions | PDXDC1 TRPM7 DOCK11 MYO9A MYO9B GART ACTB EXOC3 MCF2 DHX9 LAPTM5 FANCD2 ARHGAP22 PLEKHG1 LONP1 FAT1 PIK3C2A NUP210 VPS13A FKBP8 UTRN RASGRF2 RASA3 DOCK8 MYO19 POLR2C ARHGEF12 ADGRL1 RICTOR HEATR1 CASK CCNF CNNM3 AASS SLITRK5 TMEM131 CTNND1 | 5.69e-07 | 1323 | 234 | 37 | int:CDC42 |
| Interaction | STIP1 interactions | PDXDC1 RPL23A ARHGAP24 HSPH1 GART ACTB PSMC3 DDX1 DHX9 FANCD2 LONP1 NUP210 USP7 PRPF19 FKBP8 HECTD1 DYNC1H1 HSP90AB3P RANBP2 COPZ1 NUP107 DOCK8 POLR2C HEATR1 THOC2 CCNF USP10 MTOR NUP133 CSTF3 CTPS1 | 7.04e-07 | 1006 | 234 | 31 | int:STIP1 |
| Interaction | YWHAQ interactions | PRPF31 SPIRE2 TRPM7 DOCK11 MYO9A CEP85L HSPH1 ACTB ACTG1 ACTN2 DDX1 DHX9 FANCD2 CEP170 NFATC1 PIK3C2A RASGRP3 FGR SIPA1L2 HECTD1 DYNC1H1 KIF13B TICRR NUP107 POTEF PRR5 RICTOR CCNF MTOR AASS CTNND1 CTPS1 | 2.24e-06 | 1118 | 234 | 32 | int:YWHAQ |
| Interaction | YWHAG interactions | SPIRE2 TRPM7 DOCK11 MYO9A CEP85L CYTH1 HSPH1 SYNPO DDX1 FANCD2 CEP170 PLEKHG1 DLC1 ALMS1 PIK3C2A HELZ PRPF19 PPIE SIPA1L2 HECTD1 UTRN DYNC1H1 FBXW11 KIF13B TICRR POTEF PRR5 RICTOR CCNF MTOR AASS CTNND1 CTPS1 EIF4G3 | 3.09e-06 | 1248 | 234 | 34 | int:YWHAG |
| Interaction | RAC2 interactions | PDXDC1 TRPM7 DOCK11 ACTB FANCD2 POTEE LONP1 FAT1 PIK3C2A VPS13A USP7 FKBP8 UTRN RASA3 MYO19 ADGRL1 RICTOR CASK CNNM3 MTOR SLITRK5 TMEM131 CTNND1 | 4.12e-06 | 674 | 234 | 23 | int:RAC2 |
| Interaction | CLEC16A interactions | PDXDC1 ACTB FANCD2 CEP170 NFATC1 NUP210 VPS13A FKBP8 MTO1 SIPA1L2 RANBP2 COPZ1 NUP107 MYO19 POLR2C RICTOR HEATR1 MTOR BBS7 NUP133 TMEM131 CTNND1 | 4.56e-06 | 629 | 234 | 22 | int:CLEC16A |
| Interaction | EDNRB interactions | 5.44e-06 | 39 | 234 | 6 | int:EDNRB | |
| Interaction | SFN interactions | RPL23A SPIRE2 TRPM7 DOCK11 MYO9A SAP18 LONRF1 HSPH1 ACTG1 DRG1 FANCD2 CEP170 ALMS1 PIK3C2A USP7 PPIE SIPA1L2 HECTD1 KIF13B PRR5 RICTOR MTOR AASS | 6.35e-06 | 692 | 234 | 23 | int:SFN |
| Interaction | YWHAB interactions | PRPF31 SPIRE2 TRPM7 DOCK11 MYO9A CEP85L HSPH1 ACTB ACTG1 DHX9 FANCD2 CEP170 PIK3C2A PPIE SIPA1L2 HECTD1 DYNC1H1 FBXW11 KIF13B TICRR NUP107 POTEF PRR5 RICTOR SHOC2 CCNF MTOR AASS CTNND1 | 7.11e-06 | 1014 | 234 | 29 | int:YWHAB |
| Interaction | CCDC8 interactions | MYO1D MYO9B GART ACTG1 EXOC3 MYO5C DHX9 DRG1 FANCD2 CEP170 STXBP2 UBR5 FKBP8 HECTD1 UTRN DYNC1H1 RANBP2 HEATR1 CCNF CNNM3 BBS7 CTNND1 | 8.86e-06 | 656 | 234 | 22 | int:CCDC8 |
| Interaction | UTRN interactions | HSPH1 ACTN2 EPB41L4A DHX9 USP7 HECTD1 UTRN RICTOR THOC2 CASK CCNF EIF4G3 | 9.32e-06 | 217 | 234 | 12 | int:UTRN |
| Interaction | LSP1 interactions | 9.78e-06 | 43 | 234 | 6 | int:LSP1 | |
| Interaction | IFI16 interactions | PRPF31 SAP18 HSPH1 PSMA7 GART ACTB PSMC3 DDX1 WDR43 DHX9 DRG1 CEP170 NFATC1 USP7 HELZ PRPF19 FBXW11 NUP107 HEATR1 TLR9 USP10 NUP133 CTNND1 | 1.05e-05 | 714 | 234 | 23 | int:IFI16 |
| Interaction | WDR5 interactions | PDXDC1 RPL23A PRPF31 SAP18 PSMA7 ACTB PSMC3 ACTG1 PLIN2 DHX9 DRG1 POTEE LONP1 DLC1 UBR5 USP7 PRPF19 HECTD1 UTRN DYNC1H1 RANBP2 NUP107 PRR5 RICTOR HEATR1 CCNF SRRT USP10 MTOR CTNND1 | 1.25e-05 | 1101 | 234 | 30 | int:WDR5 |
| Interaction | LGR4 interactions | ACTB ACTG1 DHX9 PIK3C2A NUP210 PKHD1 RANBP2 POTEF HEATR1 THOC2 SRRT TRIM40 EIF4G3 | 1.27e-05 | 262 | 234 | 13 | int:LGR4 |
| Interaction | RHOF interactions | PDXDC1 MYO1D TRPM7 DOCK11 MYO9B ACTB EXOC3 POTEE LONP1 FAT1 PIK3C2A VPS13A UTRN RASA3 DOCK8 PRR5 ADGRL1 RICTOR CASK CNNM3 MTOR SLITRK5 | 1.32e-05 | 673 | 234 | 22 | int:RHOF |
| Interaction | HAPSTR1 interactions | HSPH1 TBC1D2 EXOC3 SYNPO TTC4 BIRC6 WDR43 DRG1 FANCD2 LONP1 UBR5 USP7 HELZ ATP6V1C2 FKBP8 HECTD1 HEATR1 SRRT ZFHX4 SLITRK5 NUP133 POTEI CTPS1 ATP2A3 SOS1 | 1.32e-05 | 829 | 234 | 25 | int:HAPSTR1 |
| Interaction | SIRT6 interactions | RPL23A SMG1 DOCK11 DHX9 DRG1 CEP170 ARHGAP22 FAT1 UBR5 NUP210 USP7 HECTD1 RANBP2 NUP107 POLR2C RICTOR PCDH20 SRRT USP10 NUP133 CTNND1 | 1.49e-05 | 628 | 234 | 21 | int:SIRT6 |
| Interaction | NUPR1 interactions | SAP18 GART ACTB PSMC3 ACTG1 DDX1 WDR43 DHX9 POTEE PIK3C2A USP7 PRPF19 RANBP2 NUP107 HEATR1 THOC2 CASK SRRT USP10 NUP133 CSTF3 CTNND1 | 1.65e-05 | 683 | 234 | 22 | int:NUPR1 |
| Interaction | RHOQ interactions | MYO1D TRPM7 DOCK11 EXOC3 ABCB1 PLEKHG1 FAT1 VPS13A UTRN DOCK8 PRR5 RICTOR CASK CNNM3 MTOR SLITRK5 CTNND1 | 1.74e-05 | 442 | 234 | 17 | int:RHOQ |
| Interaction | PSMA3 interactions | PSMA7 ACTB PSMC3 ACTG1 ACTN2 DDX1 FANCD2 LONP1 USP7 PRPF19 FKBP8 UTRN ADGRL1 CCNF SRRT DCLK3 CTPS1 | 1.79e-05 | 443 | 234 | 17 | int:PSMA3 |
| Interaction | SIRT7 interactions | RPL23A MYO1D GART PSMC3 BIRC6 WDR43 CEP170 LONP1 UBR5 NUP210 USP7 HELZ HECTD1 UTRN DYNC1H1 RANBP2 NUP107 HEATR1 THOC2 MTOR NUP133 ATM EIF4G3 | 2.02e-05 | 744 | 234 | 23 | int:SIRT7 |
| Interaction | ACTG2 interactions | 2.12e-05 | 49 | 234 | 6 | int:ACTG2 | |
| Interaction | CDC5L interactions | RPL23A SAP18 ACTB PSMC3 SYNPO DHX9 DRG1 FANCD2 UBR5 USP7 PRPF19 PPIE HECTD1 DYNC1H1 RANBP2 NUP107 KALRN DOCK8 SMARCAL1 RICTOR THOC2 CCNF USP10 CSTF3 CTNND1 | 2.21e-05 | 855 | 234 | 25 | int:CDC5L |
| Interaction | SNAI1 interactions | RPL23A PRPF31 MYO1D HSPH1 GART ACTB PSMC3 ACTN2 DHX9 CEP170 EFHC1 USP7 HECTD1 SMARCAL1 OTUB1 RICTOR USP10 ATM CTPS1 | 2.24e-05 | 546 | 234 | 19 | int:SNAI1 |
| Interaction | ABTB2 interactions | 2.34e-05 | 101 | 234 | 8 | int:ABTB2 | |
| Interaction | VCP interactions | PDXDC1 PRPF31 CAAP1 ARHGAP24 MYO1D SAP18 HSPH1 PSMA7 ACTB PSMC3 ACTG1 TTC4 WDR43 FANCD2 LONP1 UBR5 RAB3GAP2 USP7 PRPF19 HECTD1 DYNC1H1 FBXW11 RANBP2 COPZ1 NUP107 RICTOR HEATR1 SHOC2 CCNF USP10 IFT88 MTOR AASS CTNND1 CTPS1 | 2.38e-05 | 1435 | 234 | 35 | int:VCP |
| Interaction | YWHAE interactions | PRPF31 SPIRE2 TRPM7 DOCK11 MYO9A CEP85L CCR9 PSMA7 ACTB DHX9 FANCD2 CEP170 PIK3C2A PPIE SIPA1L2 HECTD1 DYNC1H1 FBXW11 KIF13B TICRR DOCK8 POTEF PRR5 RICTOR SHOC2 CASK CCNF MTOR AASS DEPDC5 CTNND1 RIMS2 | 2.39e-05 | 1256 | 234 | 32 | int:YWHAE |
| Interaction | RPS6KL1 interactions | 2.67e-05 | 51 | 234 | 6 | int:RPS6KL1 | |
| Interaction | MYO5A interactions | EXOC3 SYNPO MYO5C FANCD2 USP7 HECTD1 COPZ1 KALRN MYO19 RICTOR TRIM52 | 2.78e-05 | 204 | 234 | 11 | int:MYO5A |
| Interaction | TMOD3 interactions | SPIRE2 MYO1D ACTB BDH2 SYNPO MYO5C DHX9 FANCD2 MYO19 RICTOR CCNF POTEI | 2.88e-05 | 243 | 234 | 12 | int:TMOD3 |
| Interaction | NCAPH2 interactions | PRPF31 MYO9A ACTN2 ALMS1 PIK3C2A MTO1 HECTD1 RICTOR TRIM52 CCNF | 2.93e-05 | 169 | 234 | 10 | int:NCAPH2 |
| Interaction | YWHAH interactions | SPIRE2 TRPM7 DOCK11 MYO9A CEP85L HSPH1 PSMC3 DDX1 FANCD2 CEP170 PLEKHG1 ALMS1 PIK3C2A RAB3GAP2 SIPA1L2 HECTD1 UTRN KIF13B TICRR POTEF PRR5 RICTOR CCNF SRRT MTOR AASS CTNND1 EIF4G3 RIMS2 | 3.34e-05 | 1102 | 234 | 29 | int:YWHAH |
| Interaction | ARPC5L interactions | 3.71e-05 | 79 | 234 | 7 | int:ARPC5L | |
| Interaction | KIF20A interactions | RPL23A BRPF3 MYO1D LONRF1 SYNPO ACTN2 TLR6 DDX1 WDR43 DHX9 CEP170 POTEE LONP1 ALMS1 PIK3C2A UBR5 HELZ PRPF19 UTRN FBXW11 RANBP2 ADGRL1 HEATR1 THOC2 CCNF CTCFL NUP133 CTNND1 | 3.78e-05 | 1052 | 234 | 28 | int:KIF20A |
| Interaction | GSN interactions | ARHGAP24 ACTB ACTG1 SYNPO FANCD2 PLEKHG1 PIK3C2A POTEF MYO19 RICTOR POTEI | 3.96e-05 | 212 | 234 | 11 | int:GSN |
| Interaction | DNAJC7 interactions | RPL23A TDRD9 HSPH1 PSMA7 GART SYNPO FANCD2 NFATC1 PIK3C2A VPS13A MTO1 FBXW11 OTUB1 CCNF BBS7 ATM | 3.99e-05 | 425 | 234 | 16 | int:DNAJC7 |
| Interaction | LIMA1 interactions | ARHGAP24 ZBTB20 HSPH1 ACTB PSMC3 ACTG1 SYNPO MYO5C PIK3C2A USP7 UTRN KIF13B MYO19 RICTOR CCNF EIF4G3 | 4.47e-05 | 429 | 234 | 16 | int:LIMA1 |
| Interaction | DLD interactions | ARHGAP24 HSPH1 GART PSMC3 TTC4 DDX1 FANCD2 PRPF19 HECTD1 FBXW11 COPZ1 DOCK8 POLR2C OTUB1 RICTOR CCNF SRRT CSTF3 | 4.60e-05 | 526 | 234 | 18 | int:DLD |
| Interaction | KLC1 interactions | ODAD1 HSPH1 ACTB PSMC3 EXOC3 USP7 DYNC1H1 COPZ1 POLR2C OTUB1 CCNF CTPS1 | 4.60e-05 | 255 | 234 | 12 | int:KLC1 |
| Interaction | WWOX interactions | PRPF31 HSPH1 GART STYK1 BDH2 PSMC3 TTC4 DDX1 DHX9 DRG1 SCGB2A1 FKBP8 HSP90AB3P POLR2C CNNM3 MTOR NUP133 CSTF3 ATM CTPS1 | 4.65e-05 | 627 | 234 | 20 | int:WWOX |
| Interaction | FLII interactions | ACTB ACTG1 SYNPO DDX1 MYO5C DHX9 FANCD2 HECTD1 FBXW11 MYO19 POLR2C NLRP3 CCNF | 4.87e-05 | 298 | 234 | 13 | int:FLII |
| Interaction | MYO9B interactions | 5.26e-05 | 113 | 234 | 8 | int:MYO9B | |
| Interaction | HTR6 interactions | 5.62e-05 | 58 | 234 | 6 | int:HTR6 | |
| Interaction | FPR1 interactions | 5.65e-05 | 147 | 234 | 9 | int:FPR1 | |
| Interaction | FMR1 interactions | SMG1 ARHGAP24 ZSCAN12 ACTB DDX1 DHX9 DRG1 FANCD2 CEP170 POTEE EFHC1 USP7 HECTD1 DYNC1H1 RANBP2 CASK CCNF USP10 | 5.86e-05 | 536 | 234 | 18 | int:FMR1 |
| Interaction | YWHAZ interactions | PRPF31 SPIRE2 TRPM7 DOCK11 MYO9A CEP85L ACTG1 SYNPO FANCD2 CEP170 PIK3C2A PPIE SIPA1L2 HECTD1 DYNC1H1 FBXW11 GP1BA KIF13B TICRR NUP107 COL6A6 RASGRF2 POTEF PRR5 RICTOR CCNF MCTP1 MTOR AASS DEPDC5 ATM CTNND1 | 6.13e-05 | 1319 | 234 | 32 | int:YWHAZ |
| Interaction | ACTR3 interactions | PDXDC1 ACTB ACTG1 SYNPO BIRC6 MYO5C PLEKHG1 ALMS1 RASGRP3 SIPA1L2 MYO19 RICTOR CCNF | 6.17e-05 | 305 | 234 | 13 | int:ACTR3 |
| Interaction | EED interactions | PDXDC1 RPL23A MYO1D HSPH1 GART ACTB ACTG1 BIRC6 DDX1 WDR43 DHX9 FANCD2 STXBP2 PIK3C2A RAB3GAP2 NUP210 USP7 PRPF19 HECTD1 DYNC1H1 FBXW11 RANBP2 COPZ1 NUP107 MYO19 OTUB1 RICTOR HEATR1 THOC2 SRRT USP10 NUP133 CTNND1 CTPS1 | 6.47e-05 | 1445 | 234 | 34 | int:EED |
| Interaction | FAM174A interactions | PDXDC1 DYM FANCD2 STXBP2 FKBP8 MYO19 OTUB1 HEATR1 MTOR AASS ATP2A3 | 6.52e-05 | 224 | 234 | 11 | int:FAM174A |
| Interaction | PPP6C interactions | HSPH1 ACTB BIRC6 DDX1 ARHGAP22 USP7 UTRN DYNC1H1 CCNF SRRT USP10 | 7.64e-05 | 228 | 234 | 11 | int:PPP6C |
| Interaction | RACK1 interactions | RPL23A PRPF31 ZSCAN12 ACTB STYK1 ACTN2 BIRC6 DHX9 DRG1 FANCD2 NFATC1 HELZ HECTD1 RANBP2 RASA3 OTUB1 RICTOR CCNF USP10 NIM1K TMEM131 | 7.81e-05 | 704 | 234 | 21 | int:RACK1 |
| Interaction | STIL interactions | HSPH1 TSHR FANCD2 PLEKHG1 ALMS1 USP7 SIPA1L2 FBXW11 CCNF BBS7 | 7.90e-05 | 190 | 234 | 10 | int:STIL |
| Interaction | DQX1 interactions | 9.08e-05 | 21 | 234 | 4 | int:DQX1 | |
| Interaction | HUWE1 interactions | SAP18 HSPH1 PSMA7 PSMC3 TTC4 BIRC6 DDX1 DRG1 LAPTM5 FANCD2 UBR5 USP7 PRPF19 PPIE FKBP8 HECTD1 DYNC1H1 FBXW11 RANBP2 NUP107 POLR2C ARHGEF12 HEATR1 SHOC2 CCNF NUP133 ATM CTPS1 | 9.55e-05 | 1110 | 234 | 28 | int:HUWE1 |
| Interaction | DHX9 interactions | ACTB EXOC3 TLR8 DDX1 STAT6 ABCB1 DHX9 DRG1 FANCD2 USP7 PPIE HECTD1 UTRN FBXW11 RANBP2 RICTOR THOC2 CCNF SRRT USP10 | 9.78e-05 | 662 | 234 | 20 | int:DHX9 |
| Interaction | PFN1 interactions | ARHGAP24 MYO9A MYO9B ACTB ACTG1 BIRC6 STAT2 MYO5C FANCD2 ALMS1 PIK3C2A SIPA1L2 HECTD1 RANBP2 DOCK8 ARHGEF12 CCNF | 1.01e-04 | 509 | 234 | 17 | int:PFN1 |
| Interaction | EGLN3 interactions | MYOG HSPH1 GART PSMC3 TTC4 BIRC6 DRG1 CEP170 NFATC1 PIK3C2A UBR5 USP7 HELZ PRPF19 FKBP8 SIPA1L2 HECTD1 UTRN DYNC1H1 TICRR RANBP2 COPZ1 NUP107 POLR2C OTUB1 RICTOR RBM20 NUP133 TMEM131 CTNND1 CTPS1 | 1.04e-04 | 1296 | 234 | 31 | int:EGLN3 |
| Interaction | CKAP2 interactions | 1.14e-04 | 126 | 234 | 8 | int:CKAP2 | |
| Interaction | RAC1 interactions | TRPM7 DOCK11 ACTB EXOC3 MCF2 DHX9 FANCD2 ARHGAP22 PLEKHG1 LONP1 FAT1 VPS13A UTRN RASGRF2 RASA3 KALRN DOCK8 MYO19 PRR5 ADGRL1 RICTOR CASK CNNM3 MTOR SLITRK5 CTNND1 SOS1 | 1.15e-04 | 1063 | 234 | 27 | int:RAC1 |
| Interaction | DBN1 interactions | ARHGAP24 MYO1D GART ACTB STYK1 ACTG1 SYNPO MYO5C FANCD2 PIK3C2A UBR5 USP7 MYO19 CCNF NUP133 | 1.16e-04 | 417 | 234 | 15 | int:DBN1 |
| Interaction | TPR interactions | SAP18 ACTG1 DDX1 FANCD2 USP7 DYNC1H1 RANBP2 NUP107 DOCK8 OTUB1 CCNF NUP133 | 1.16e-04 | 281 | 234 | 12 | int:TPR |
| Interaction | CAD interactions | ARHGAP24 HSPH1 ACTB PSMC3 ACTG1 FANCD2 NFATC1 UBR5 PRPF19 FGR POLR2C OTUB1 RICTOR CCNF USP10 | 1.19e-04 | 418 | 234 | 15 | int:CAD |
| Interaction | CTNNB1 interactions | RPL23A ARHGAP24 HSPH1 ACTB PSMC3 ACTG1 DDX1 DHX9 FANCD2 UBR5 USP7 PRPF19 PPIE SIPA1L2 HECTD1 UTRN DYNC1H1 FBXW11 RANBP2 OTUB1 CCNF KIFAP3 USP10 AASS CTNND1 CDH3 | 1.23e-04 | 1009 | 234 | 26 | int:CTNNB1 |
| Interaction | PRR5L interactions | 1.32e-04 | 23 | 234 | 4 | int:PRR5L | |
| Interaction | RHOD interactions | PDXDC1 TRPM7 EXOC3 LONP1 PIK3C2A VPS13A FKBP8 UTRN RASA3 MYO19 PRR5 ADGRL1 RICTOR CASK CNNM3 MTOR SLITRK5 CTNND1 | 1.33e-04 | 572 | 234 | 18 | int:RHOD |
| Interaction | SSH2 interactions | 1.36e-04 | 43 | 234 | 5 | int:SSH2 | |
| Interaction | ADAR interactions | ARHGAP24 DHX9 FANCD2 POTEE USP7 HECTD1 FBXW11 RANBP2 POTEF THOC2 CCNF POTEI | 1.37e-04 | 286 | 234 | 12 | int:ADAR |
| Interaction | FXR1 interactions | SMG1 PRPF31 ACTB PSMC3 ACTG1 ACTN2 DDX1 FANCD2 CEP170 ARHGAP22 NFATC1 USP7 HELZ FGR HECTD1 RANBP2 RICTOR THOC2 CCNF USP10 | 1.37e-04 | 679 | 234 | 20 | int:FXR1 |
| Interaction | RHOA interactions | PDXDC1 TRPM7 MYO9A MYO9B MCF2 DDX1 FANCD2 ARHGAP22 LONP1 FAT1 DLC1 PIK3C2A NUP210 VPS13A PPIE FKBP8 UTRN RASGRF2 MYO19 POLR2C OTUB1 ARHGEF12 ADGRL1 RICTOR HEATR1 CNNM3 SLITRK5 CTNND1 CDH3 | 1.47e-04 | 1199 | 234 | 29 | int:RHOA |
| Interaction | RSPH1 interactions | 1.49e-04 | 131 | 234 | 8 | int:RSPH1 | |
| Interaction | RUFY1 interactions | RPL23A HSPH1 PSMC3 ACTG1 TTC4 DHX9 USP7 HELZ PRPF19 FKBP8 DYNC1H1 HSP90AB3P RANBP2 COPZ1 OTUB1 CCNF | 1.50e-04 | 476 | 234 | 16 | int:RUFY1 |
| Interaction | DISC1 interactions | ACTG1 ACTN2 DDX1 AK3 CEP170 ALMS1 UBR5 NUP210 USP7 UTRN DYNC1H1 KALRN SHOC2 TRIM52 KIFAP3 | 1.58e-04 | 429 | 234 | 15 | int:DISC1 |
| Interaction | ACLY interactions | ARHGAP24 ACTB PSMC3 FANCD2 STXBP2 USP7 PRPF19 COPZ1 NUP107 OTUB1 RICTOR CCNF SRRT | 1.58e-04 | 335 | 234 | 13 | int:ACLY |
| Interaction | SON interactions | SAP18 BIRC6 DHX9 FANCD2 UBR5 PRPF19 HECTD1 FBXW11 CCNF KIFAP3 | 1.66e-04 | 208 | 234 | 10 | int:SON |
| Interaction | TLR8 interactions | 1.75e-04 | 10 | 234 | 3 | int:TLR8 | |
| Interaction | APC interactions | SYNPO EPB41L4A UBR5 USP7 HECTD1 FBXW11 RANBP2 COPZ1 NUP107 ADGRL1 RICTOR MAP10 CASK KIFAP3 | 1.94e-04 | 389 | 234 | 14 | int:APC |
| Interaction | LURAP1 interactions | 2.03e-04 | 137 | 234 | 8 | int:LURAP1 | |
| Interaction | RICTOR interactions | RPL23A MYO1D GART STYK1 ACTG1 DHX9 FANCD2 LONP1 UBR5 RAB3GAP2 FKBP8 UTRN DYNC1H1 HSP90AB3P PRR5 RICTOR TRIM52 CCNF MTOR SLITRK5 DEPDC5 | 2.20e-04 | 759 | 234 | 21 | int:RICTOR |
| Interaction | SND1 interactions | RPL23A ARHGAP24 BDH2 PSMC3 STAT6 DHX9 FANCD2 FKBP8 HECTD1 RICTOR CCNF USP10 AASS | 2.22e-04 | 347 | 234 | 13 | int:SND1 |
| Interaction | PDCD4 interactions | 2.23e-04 | 176 | 234 | 9 | int:PDCD4 | |
| Interaction | GUSBP5 interactions | 2.37e-04 | 75 | 234 | 6 | int:GUSBP5 | |
| Interaction | FLNB interactions | HSPH1 GART ACTB ACTG1 SYNPO TSHR FANCD2 NUP210 GP1BA MYO19 RICTOR CCNF | 2.41e-04 | 304 | 234 | 12 | int:FLNB |
| Interaction | GSPT1 interactions | RPL23A SMG1 ARHGAP24 HSPH1 DHX9 DRG1 UBR5 DYNC1H1 CCNF USP10 CTPS1 EIF4G3 | 2.56e-04 | 306 | 234 | 12 | int:GSPT1 |
| Interaction | CTTN interactions | RPL23A ARHGAP24 GART ACTB ACTG1 SYNPO MYO5C USP7 RANBP2 MYO19 RICTOR CCNF SRRT ATM CTNND1 | 2.63e-04 | 450 | 234 | 15 | int:CTTN |
| Interaction | EIF4E interactions | 2.71e-04 | 221 | 234 | 10 | int:EIF4E | |
| Interaction | CDH5 interactions | 2.84e-04 | 109 | 234 | 7 | int:CDH5 | |
| Interaction | ADD3 interactions | 2.85e-04 | 144 | 234 | 8 | int:ADD3 | |
| Interaction | BRCA1 interactions | RPL23A LONRF1 HSPH1 PSMA7 GART PSMC3 ACTG1 DDX1 DHX9 DRG1 FANCD2 CEP170 ALMS1 UBR5 USP7 PRPF19 DYNC1H1 MMS22L SLF1 NUP107 POLR2C PRR5 RICTOR SIM2 CTCFL MTOR NUP133 ATM CTPS1 | 2.92e-04 | 1249 | 234 | 29 | int:BRCA1 |
| Interaction | CLIP1 interactions | 2.98e-04 | 183 | 234 | 9 | int:CLIP1 | |
| Interaction | RPGRIP1L interactions | CEP170 PLEKHG1 LONP1 EXOC6B SIPA1L2 HECTD1 DYNC1H1 TRIM52 NUP133 CTPS1 | 3.13e-04 | 225 | 234 | 10 | int:RPGRIP1L |
| Interaction | SSH1 interactions | 3.15e-04 | 79 | 234 | 6 | int:SSH1 | |
| Interaction | PHACTR2 interactions | 3.35e-04 | 29 | 234 | 4 | int:PHACTR2 | |
| Interaction | TMOD4 interactions | 3.35e-04 | 29 | 234 | 4 | int:TMOD4 | |
| Interaction | EIF4G3 interactions | 3.42e-04 | 148 | 234 | 8 | int:EIF4G3 | |
| Interaction | TGM1 interactions | ARHGAP24 ZSCAN12 FANCD2 RICTOR CCNF CNNM3 SRRT CSTF3 EIF4G3 SLC37A4 | 3.48e-04 | 228 | 234 | 10 | int:TGM1 |
| Interaction | HSP90AA1 interactions | RPL23A SMG1 ARHGAP24 ZBTB20 HSPH1 STYK1 ACTG1 MCF2 TTC4 STAT2 FANCD2 LONP1 LMLN PRPF19 PPIE FKBP8 FGR DYNC1H1 FBXW11 HSP90AB3P RICTOR SIM2 THOC2 NLRP3 RBCK1 CCNF SRRT MTOR AASS | 3.51e-04 | 1263 | 234 | 29 | int:HSP90AA1 |
| Interaction | MOB3C interactions | DOCK11 HSPH1 PSMA7 PSMC3 DDX1 UBR5 USP7 PRPF19 FKBP8 DYNC1H1 RANBP2 CTNND1 CTPS1 | 3.52e-04 | 364 | 234 | 13 | int:MOB3C |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.59e-06 | 66 | 168 | 7 | 722 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 7.77e-06 | 5 | 168 | 3 | 1333 | |
| GeneFamily | Myosins, class IX | 8.58e-05 | 2 | 168 | 2 | 1103 | |
| GeneFamily | CD molecules|Toll like receptors | 9.01e-05 | 10 | 168 | 3 | 948 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | ARHGAP24 DOCK11 CYTH1 ARHGAP22 PLEKHG1 RASGRF2 RASA3 SOS1 SOS2 | 1.35e-04 | 206 | 168 | 9 | 682 |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 2.10e-04 | 13 | 168 | 3 | 685 | |
| GeneFamily | Nucleoporins | 2.11e-04 | 32 | 168 | 4 | 1051 | |
| GeneFamily | Actins | 1.26e-03 | 6 | 168 | 2 | 929 | |
| GeneFamily | Exocyst complex | 2.96e-03 | 9 | 168 | 2 | 1055 | |
| Coexpression | GABRIELY_MIR21_TARGETS | ZBTB20 TRPM7 MYO9A PIK3C2A UBR5 RASGRP3 RAB3GAP2 VPS13A USP7 HECTD1 UTRN ARHGEF12 LMBR1 THOC2 | 3.94e-07 | 289 | 235 | 14 | M2196 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GALK2 ZBTB20 MYO9B CYTH1 WDR43 CEP170 FAT1 DLC1 PIK3C2A UBR5 VPS13A USP7 HELZ FBXW11 RANBP2 THOC2 SHOC2 CASK KIFAP3 NUP133 TMEM131 EIF4G3 SOS1 SOS2 | 8.97e-07 | 856 | 235 | 24 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.60e-06 | 180 | 235 | 10 | M8239 | |
| Coexpression | WANG_LMO4_TARGETS_DN | LONRF1 EXOC3 UBR5 EXOC6B SIPA1L2 DYNC1H1 FBXW11 KALRN RICTOR CASK TRMT10A CTNND1 EIF4G3 | 2.54e-05 | 361 | 235 | 13 | M12674 |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 3.33e-05 | 177 | 235 | 9 | M9401 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 3.43e-05 | 137 | 235 | 8 | M39241 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADCY8 PKHD1 WDR17 DNAH9 TRHDE KCTD19 LAMA2 SIM2 TECTA PTPRT ZFHX4 AASS | 6.37e-11 | 160 | 236 | 12 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADCY8 PKHD1 WDR17 DNAH9 TRHDE KCTD19 LAMA2 SIM2 TECTA PTPRT ZFHX4 AASS | 6.37e-11 | 160 | 236 | 12 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | ABCA3 DOCK11 MYO9B CYTH1 HSPH1 TBC1D2 STAT2 STAT6 LAPTM5 UTRN DOCK8 PIK3R5 | 7.94e-10 | 199 | 236 | 12 | 155b03b859157013e9142e9248551369127d9204 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | SMG1 ZBTB20 TRPM7 CEP85L HSPH1 BIRC6 UTRN DYNC1H1 RANBP2 RICTOR TMEM131 | 5.59e-09 | 188 | 236 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | EPB41L4A BIRC6 DLC1 PIK3C2A UBR5 UTRN ROBO4 SLF1 ARHGEF12 MCTP1 CTNND1 | 1.06e-08 | 200 | 236 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYO1D DOCK11 MYO9A PROM1 ADAMTS9 PKHD1 UTRN TRHDE SIM2 PTPRT | 6.87e-08 | 188 | 236 | 10 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | EPB41L4A ABCB1 PLEKHG1 DLC1 ROBO4 SLF1 EDNRB MCTP1 CTNND1 CDH13 | 7.97e-08 | 191 | 236 | 10 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | EPB41L4A ABCB1 PLEKHG1 RASGRP3 SIPA1L2 ROBO4 ARHGEF12 EDNRB MCTP1 CTNND1 | 9.23e-08 | 194 | 236 | 10 | 43f92b0533e26633dc94cce554045d641ef8fd76 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | EPB41L4A ABCB1 PLEKHG1 RASGRP3 SIPA1L2 ROBO4 ARHGEF12 EDNRB MCTP1 CTNND1 | 9.23e-08 | 194 | 236 | 10 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | HEXB MYO9B TBC1D2 PLIN2 CEP170 ARHGAP22 RASGRP3 FGR SIPA1L2 PIK3R5 | 9.68e-08 | 195 | 236 | 10 | 9d649ac7d2af313481069c95349efc0c68449e2b |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | EPB41L4A ABCB1 PLEKHG1 PIK3C2A ADAMTS9 ROBO4 RASGRF2 KALRN MCTP1 CDH13 | 1.06e-07 | 197 | 236 | 10 | ab6d1ab586a188597a39854ef980b8955ebcc645 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | DOCK11 ACTB STAT6 PLIN2 LAPTM5 DENND4B FGR UTRN DOCK8 PIK3R5 | 1.17e-07 | 199 | 236 | 10 | 379bbd9cecf466b902411c54d74bd9885285b1ba |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DOCK11 CD209 LAPTM5 ARHGAP22 FGR DOCK8 AOAH NLRP3 MCTP1 PIK3R5 | 1.23e-07 | 200 | 236 | 10 | ad7ae5106141669b353800fece833b3cd5bdccee |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-07 | 168 | 236 | 9 | 80233a13135fd159f5764336a1fe67fba237776b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-07 | 176 | 236 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-07 | 176 | 236 | 9 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-07 | 177 | 236 | 9 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 5.29e-07 | 180 | 236 | 9 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-07 | 184 | 236 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-07 | 184 | 236 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-07 | 184 | 236 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | CYTH1 SYNPO PLIN2 PLEKHG1 ADAMTS9 SIPA1L2 RASGRF2 KALRN EDNRB | 6.66e-07 | 185 | 236 | 9 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.96e-07 | 186 | 236 | 9 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP24 MYO9A ARHGAP22 ADAMTS9 PKHD1 TRHDE SIM2 IFT88 RIMS2 | 7.28e-07 | 187 | 236 | 9 | c31130fc2f9f882944b2ba366a034a03f051c4b9 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-07 | 188 | 236 | 9 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | EPB41L4A MYO5C ABCB1 PLEKHG1 PIK3C2A ADAMTS9 RASGRF2 KALRN MCTP1 | 8.32e-07 | 190 | 236 | 9 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.69e-07 | 191 | 236 | 9 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.07e-07 | 192 | 236 | 9 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 9.47e-07 | 193 | 236 | 9 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.47e-07 | 193 | 236 | 9 | 888b11d7d66970931d1c33bea714659ca3cfe149 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CEP85L ABCB1 PLEKHG1 SIPA1L2 ROBO4 ARHGEF12 EDNRB MCTP1 CTNND1 | 9.47e-07 | 193 | 236 | 9 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | ABCB1 PLEKHG1 PIK3C2A ADAMTS9 UTRN ROBO4 RASGRF2 KALRN MCTP1 | 9.47e-07 | 193 | 236 | 9 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ABCB1 PLEKHG1 RASGRP3 ROBO4 SLF1 ARHGEF12 EDNRB MCTP1 CTNND1 | 9.47e-07 | 193 | 236 | 9 | 02f633b016ab19bfa65bfd0cf32f000549a62148 |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CEP85L ABCB1 PLEKHG1 RASGRP3 SIPA1L2 EDNRB MCTP1 EIF4G3 CDH13 | 9.47e-07 | 193 | 236 | 9 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CEP85L ABCB1 PLEKHG1 RASGRP3 SIPA1L2 EDNRB MCTP1 EIF4G3 CDH13 | 9.47e-07 | 193 | 236 | 9 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ABCB1 PLEKHG1 RASGRP3 ROBO4 SLF1 ARHGEF12 EDNRB MCTP1 CTNND1 | 9.47e-07 | 193 | 236 | 9 | 5122b1ffba42de190061be34ecdc6176f84e56a3 |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.89e-07 | 194 | 236 | 9 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | EPB41L4A PLEKHG1 DLC1 RASGRP3 SIPA1L2 SLF1 ARHGEF12 MCTP1 CTNND1 | 9.89e-07 | 194 | 236 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | EPB41L4A ABCB1 PLEKHG1 PIK3C2A ADAMTS9 ROBO4 RASGRF2 KALRN MCTP1 | 1.03e-06 | 195 | 236 | 9 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 1.03e-06 | 195 | 236 | 9 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 1.03e-06 | 195 | 236 | 9 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SYNPO PLEKHG1 DLC1 PIK3C2A ADAMTS9 ROBO4 RASGRF2 KALRN CDH13 | 1.08e-06 | 196 | 236 | 9 | 7cbb19108b4553ef60ef5c230a29de1662c02efe |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SYNPO PLEKHG1 DLC1 PIK3C2A ADAMTS9 ROBO4 RASGRF2 KALRN CDH13 | 1.08e-06 | 196 | 236 | 9 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-06 | 197 | 236 | 9 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | EPB41L4A ABCB1 PLEKHG1 PIK3C2A UTRN ROBO4 RASGRF2 KALRN MCTP1 | 1.12e-06 | 197 | 236 | 9 | f9731d4d636e51b94a96805eee6afe9aedc175e3 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 197 | 236 | 9 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-06 | 197 | 236 | 9 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.12e-06 | 197 | 236 | 9 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.17e-06 | 198 | 236 | 9 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 198 | 236 | 9 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 198 | 236 | 9 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-06 | 199 | 236 | 9 | 04adf46975aa4194ea40c7480f8a517def5d929c | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-06 | 199 | 236 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 3'-Parenchyma_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-06 | 199 | 236 | 9 | bc064ccfec8c1e96079b89b05aeebddf48bc87f3 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-06 | 199 | 236 | 9 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 200 | 236 | 9 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.27e-06 | 200 | 236 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-06 | 170 | 236 | 8 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-06 | 171 | 236 | 8 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 172 | 236 | 8 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.92e-06 | 172 | 236 | 8 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 172 | 236 | 8 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 4.09e-06 | 173 | 236 | 8 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.26e-06 | 179 | 236 | 8 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-06 | 180 | 236 | 8 | eedb6d89680f968167afb1dcd132c9de9096b50f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-06 | 181 | 236 | 8 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-06 | 181 | 236 | 8 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.94e-06 | 182 | 236 | 8 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-06 | 183 | 236 | 8 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-06 | 183 | 236 | 8 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.18e-06 | 183 | 236 | 8 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | PBMC-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 6.70e-06 | 185 | 236 | 8 | 4b5a7450fed912f340da16065c1e65d626dbe8d1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 186 | 236 | 8 | bec4767eaca28e41da373274704895eba75063e2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.97e-06 | 186 | 236 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.97e-06 | 186 | 236 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-06 | 187 | 236 | 8 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.24e-06 | 187 | 236 | 8 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 7.53e-06 | 188 | 236 | 8 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.83e-06 | 135 | 236 | 7 | 8521107817df49efd9a2e81078c8535ed33e729c | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.83e-06 | 189 | 236 | 8 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.83e-06 | 189 | 236 | 8 | 440c422369de1c49112d18cf8c506a2a3a81f6ba | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.83e-06 | 189 | 236 | 8 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.83e-06 | 189 | 236 | 8 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 8.14e-06 | 190 | 236 | 8 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.14e-06 | 190 | 236 | 8 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.14e-06 | 190 | 236 | 8 | 6a70d92cf66bdc9dade218b530f040f1581926f1 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 8.14e-06 | 190 | 236 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 191 | 236 | 8 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 191 | 236 | 8 | 79c83a710aa17fc06f286e4ea2011ed9e30e3bc6 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 8.46e-06 | 191 | 236 | 8 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 8.46e-06 | 191 | 236 | 8 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.78e-06 | 192 | 236 | 8 | 0ba5729a890bfba5db567cd0eec7924cd1991ac3 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 192 | 236 | 8 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.78e-06 | 192 | 236 | 8 | aa65557b35d3eba9f24b970849255d05174d1c05 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.78e-06 | 192 | 236 | 8 | d44f46352bac414b45cc749f7cbdc3a159bd7ae8 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 192 | 236 | 8 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 8.78e-06 | 192 | 236 | 8 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.12e-06 | 193 | 236 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-06 | 193 | 236 | 8 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-06 | 193 | 236 | 8 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| Drug | guanine | ARHGAP24 MYO9B CYTH1 GART MCF2 TLR8 ADCY8 PLIN2 RASGRP3 LMLN PRPF19 FKBP8 KIF13B RANBP2 RASGRF2 RASA3 ARHGEF12 XDH EDNRB CASK KIFAP3 MTOR CTNND1 CTPS1 SOS1 SOS2 | 2.26e-06 | 902 | 234 | 26 | CID000000764 |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; HL60; HT_HG-U133A | 4.87e-06 | 191 | 234 | 11 | 6142_DN | |
| Drug | rottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA | TBC1D2 MCF2 SYNPO TLR8 NME8 SIM2 NLRP3 MCTP1 PKD2L2 AASS RIMS2 | 6.23e-06 | 196 | 234 | 11 | 825_UP |
| Disease | Colorectal Carcinoma | ABCA3 TRPM7 ABCA9 ADCY8 ABCB1 PROM1 FAT1 DLC1 NFATC1 VPS13A PKHD1 DNAH8 RASGRF2 KALRN TLR9 PTPRT PIK3R5 | 3.46e-05 | 702 | 227 | 17 | C0009402 |
| Disease | obsolete_red blood cell distribution width | MYO1D MYO9B CYTH1 BIRC6 AK3 PLIN2 ABCB1 CEP170 PLEKHG1 LONP1 SULT2A1 NUP210 VPS13A FKBP8 COPZ1 KALRN DOCK8 MYO19 AOAH NLRP3 CCNF SV2C EIF4G3 LRRC37B CDH3 | 4.59e-05 | 1347 | 227 | 25 | EFO_0005192 |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 5.89e-05 | 2 | 227 | 2 | C1855722 | |
| Disease | Baraitser-Winter syndrome | 5.89e-05 | 2 | 227 | 2 | cv:C1853623 | |
| Disease | Fryns-Aftimos Syndrome | 5.89e-05 | 2 | 227 | 2 | C1853623 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 6.04e-05 | 28 | 227 | 4 | DOID:5409 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | RPL23A ABCA3 CEP85L PKDREJ NME8 ABCB1 DNAH9 RASGRF2 KALRN SMARCAL1 LAMA2 XDH TECTA PCDH20 EDNRB TRMT10A GUCY2F MTOR NUP133 ATM ATP2A3 | 9.34e-05 | 1074 | 227 | 21 | C0006142 |
| Disease | Large cell carcinoma of lung | 1.04e-04 | 32 | 227 | 4 | C0345958 | |
| Disease | Malformations of Cortical Development | 1.54e-04 | 14 | 227 | 3 | C1955869 | |
| Disease | Cortical Dysplasia | 1.54e-04 | 14 | 227 | 3 | C0431380 | |
| Disease | Adenoma | 1.66e-04 | 36 | 227 | 4 | C0001430 | |
| Disease | Adenoma, Microcystic | 1.66e-04 | 36 | 227 | 4 | C0205648 | |
| Disease | Adenoma, Monomorphic | 1.66e-04 | 36 | 227 | 4 | C0205649 | |
| Disease | Adenoma, Basal Cell | 1.66e-04 | 36 | 227 | 4 | C0205646 | |
| Disease | Follicular adenoma | 1.66e-04 | 36 | 227 | 4 | C0205647 | |
| Disease | Papillary adenoma | 1.66e-04 | 36 | 227 | 4 | C0205650 | |
| Disease | Adenoma, Trabecular | 1.66e-04 | 36 | 227 | 4 | C0205651 | |
| Disease | extrapulmonary tuberculosis (is_implicated_in) | 1.76e-04 | 3 | 227 | 2 | DOID:0050598 (is_implicated_in) | |
| Disease | X-12093 measurement | 1.76e-04 | 3 | 227 | 2 | EFO_0021285 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 1.91e-04 | 15 | 227 | 3 | EFO_0009935 | |
| Disease | Glioblastoma Multiforme | 2.24e-04 | 111 | 227 | 6 | C1621958 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 2.34e-04 | 16 | 227 | 3 | C0334634 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.34e-04 | 16 | 227 | 3 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Carcinomatosis | 2.80e-04 | 163 | 227 | 7 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 2.80e-04 | 163 | 227 | 7 | C0205697 | |
| Disease | Undifferentiated carcinoma | 2.80e-04 | 163 | 227 | 7 | C0205698 | |
| Disease | Anaplastic carcinoma | 2.80e-04 | 163 | 227 | 7 | C0205696 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 2.82e-04 | 17 | 227 | 3 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Carcinoma | 2.91e-04 | 164 | 227 | 7 | C0007097 | |
| Disease | Polydactyly | 2.98e-04 | 117 | 227 | 6 | C0152427 | |
| Disease | pulmonary tuberculosis (is_implicated_in) | 3.04e-04 | 42 | 227 | 4 | DOID:2957 (is_implicated_in) | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 3.97e-04 | 19 | 227 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 3.97e-04 | 19 | 227 | 3 | C1843181 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 3.97e-04 | 19 | 227 | 3 | DOID:10003 (implicated_via_orthology) | |
| Disease | Cardio-facio-cutaneous syndrome | 3.97e-04 | 19 | 227 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 3.97e-04 | 19 | 227 | 3 | C0587248 | |
| Disease | Infiltrating duct carcinoma of female breast | 5.39e-04 | 21 | 227 | 3 | C3165106 | |
| Disease | N2-acetyl,N6-methyllysine measurement | 5.80e-04 | 5 | 227 | 2 | EFO_0800109 | |
| Disease | Galloway-Mowat syndrome (is_implicated_in) | 5.80e-04 | 5 | 227 | 2 | DOID:0080694 (is_implicated_in) | |
| Disease | mastiha supplement exposure measurement, blood glutathione peroxidase measurement | 5.80e-04 | 5 | 227 | 2 | EFO_0600067, EFO_0600071 | |
| Disease | LEOPARD Syndrome | 6.21e-04 | 22 | 227 | 3 | C0175704 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 6.21e-04 | 22 | 227 | 3 | EFO_0021115 | |
| Disease | smoking status measurement | CAAP1 GALK2 ZBTB20 TBC1D2 ACTN2 BIRC6 ADCY8 DLC1 ALMS1 RAB3GAP2 PKHD1 FKBP8 DNAH8 UTRN TRHDE MMS22L RASGRF2 LAMA2 MCTP1 EIF4G3 | 6.88e-04 | 1160 | 227 | 20 | EFO_0006527 |
| Disease | hair morphology measurement | 7.98e-04 | 54 | 227 | 4 | EFO_0007821 | |
| Disease | Noonan Syndrome | 8.07e-04 | 24 | 227 | 3 | C0028326 | |
| Disease | 4-androsten-3beta,17beta-diol disulfate 1 measurement | 8.66e-04 | 6 | 227 | 2 | EFO_0021113 | |
| Disease | attention function measurement | 1.03e-03 | 148 | 227 | 6 | EFO_0007636 | |
| Disease | urate measurement, spine bone mineral density | 1.05e-03 | 58 | 227 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | retinal layer thickness measurement | 1.19e-03 | 60 | 227 | 4 | EFO_0600002 | |
| Disease | Uveoretinal Coloboma | 1.21e-03 | 7 | 227 | 2 | C4554007 | |
| Disease | bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 measurement | 1.21e-03 | 7 | 227 | 2 | EFO_0802332 | |
| Disease | stimulant use measurement | 1.28e-03 | 28 | 227 | 3 | EFO_0600076 | |
| Disease | reticulocyte measurement | SPIRE2 ZBTB20 MYO1D MYO9B ACTB BIRC6 ADCY8 FAT1 VPS13A COPZ1 POTEF RICTOR USP10 SV2C DEPDC5 TMEM131 CTNND1 TRIM40 | 1.40e-03 | 1053 | 227 | 18 | EFO_0010700 |
| Disease | eosinophil measurement | 1.51e-03 | 108 | 227 | 5 | EFO_0803540 | |
| Disease | body surface area | PDXDC1 BRPF3 DYM MYO9B CYTH1 DLC1 PKHD1 FBXW11 TICRR ARHGEF12 MTOR CTPS1 CDH13 | 1.53e-03 | 643 | 227 | 13 | EFO_0022196 |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1.56e-03 | 30 | 227 | 3 | C1868672 | |
| Disease | aspergillosis (is_implicated_in) | 1.60e-03 | 8 | 227 | 2 | DOID:13564 (is_implicated_in) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.60e-03 | 8 | 227 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.60e-03 | 8 | 227 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | memory impairment | 1.60e-03 | 8 | 227 | 2 | EFO_0001072 | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.60e-03 | 8 | 227 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | nemaline myopathy (implicated_via_orthology) | 1.60e-03 | 8 | 227 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | Galloway Mowat syndrome | 1.60e-03 | 8 | 227 | 2 | C0795949 | |
| Disease | N2,N2-dimethylguanosine measurement | 1.60e-03 | 8 | 227 | 2 | EFO_0021125 | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.60e-03 | 8 | 227 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.69e-03 | 163 | 227 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Benign Neoplasm | 1.89e-03 | 68 | 227 | 4 | C0086692 | |
| Disease | Neoplasms | 1.89e-03 | 68 | 227 | 4 | C0027651 | |
| Disease | corticobasal degeneration disorder | 2.05e-03 | 9 | 227 | 2 | MONDO_0022308 | |
| Disease | temporal lobe epilepsy (implicated_via_orthology) | 2.05e-03 | 9 | 227 | 2 | DOID:3328 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 2.05e-03 | 9 | 227 | 2 | C0085548 | |
| Disease | Focal Segmental Glomerulosclerosis, Not Otherwise Specified | 2.05e-03 | 9 | 227 | 2 | C4049702 | |
| Disease | gallbladder neoplasm | 2.05e-03 | 9 | 227 | 2 | EFO_0004606 | |
| Disease | acquired immunodeficiency syndrome (is_implicated_in) | 2.05e-03 | 9 | 227 | 2 | DOID:635 (is_implicated_in) | |
| Disease | Congenital ocular coloboma (disorder) | 2.05e-03 | 9 | 227 | 2 | C0009363 | |
| Disease | thoracic aortic calcification measurement | 2.05e-03 | 9 | 227 | 2 | EFO_0010273 | |
| Disease | androsterone sulfate measurement | 2.07e-03 | 33 | 227 | 3 | EFO_0021117 | |
| Disease | Malignant neoplasm of stomach | 2.36e-03 | 300 | 227 | 8 | C0024623 | |
| Disease | Congenital neurologic anomalies | 2.55e-03 | 10 | 227 | 2 | C0497552 | |
| Disease | Cranioschisis | 2.55e-03 | 10 | 227 | 2 | C0265541 | |
| Disease | allergic conjunctivitis (is_marker_for) | 2.55e-03 | 10 | 227 | 2 | DOID:11204 (is_marker_for) | |
| Disease | intestinal atresia (implicated_via_orthology) | 2.55e-03 | 10 | 227 | 2 | DOID:10486 (implicated_via_orthology) | |
| Disease | platelet glycoprotein ib alpha chain measurement | 2.55e-03 | 10 | 227 | 2 | EFO_0020645 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 2.55e-03 | 10 | 227 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 2.55e-03 | 10 | 227 | 2 | EFO_0800289 | |
| Disease | pulse pressure measurement | TDRD15 BRPF3 ARHGAP24 TRPM7 CYTH1 BDH2 PLIN2 PLEKHG1 PROM1 DLC1 CEP120 STXBP2 PIK3C2A FGR FUT10 OTUB1 ARHGEF12 ZFHX4 CTNND1 CDH13 SOS2 | 2.62e-03 | 1392 | 227 | 21 | EFO_0005763 |
| Disease | Primary ciliary dyskinesia | 2.66e-03 | 36 | 227 | 3 | cv:C0008780 | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 2.66e-03 | 36 | 227 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | chronic kidney disease, diabetic nephropathy | 2.66e-03 | 36 | 227 | 3 | EFO_0000401, EFO_0003884 | |
| Disease | loneliness measurement | 2.77e-03 | 124 | 227 | 5 | EFO_0007865 | |
| Disease | Noonan Syndrome 1 | 3.10e-03 | 11 | 227 | 2 | C4551602 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 3.10e-03 | 11 | 227 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | Turner Syndrome, Male | 3.10e-03 | 11 | 227 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 3.10e-03 | 11 | 227 | 2 | C1527404 | |
| Disease | venous thromboembolism | 3.15e-03 | 460 | 227 | 10 | EFO_0004286 | |
| Disease | Malignant Neoplasms | 3.17e-03 | 128 | 227 | 5 | C0006826 | |
| Disease | Glioblastoma | 3.27e-03 | 79 | 227 | 4 | C0017636 | |
| Disease | white matter microstructure measurement | SPIRE2 PLEKHG1 NFATC1 RASGRP3 AGBL1 SMARCAL1 EIF4G3 CDH13 SOS1 | 3.40e-03 | 390 | 227 | 9 | EFO_0005674 |
| Disease | multiple system atrophy | 3.60e-03 | 40 | 227 | 3 | EFO_1001050 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 3.70e-03 | 12 | 227 | 2 | OBA_2045152 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NIPLEIIRYLSEEKD | 736 | Q9UKU6 | |
| NIETYLIKQPEDSLL | 581 | P40145 | |
| VRIPEQTYITLKLED | 71 | Q5SW79 | |
| TKVPLLLEILDSYDQ | 691 | Q8IWZ6 | |
| EDPSIIAEILSVYQK | 666 | Q9NUB1 | |
| RILASDKPYILAEEL | 836 | P35609 | |
| TLPVLLLYSIKESDE | 626 | Q9NR09 | |
| NYATRIVTLEEEPIK | 831 | Q9NR09 | |
| LLVPDIQKTAEIVYA | 4476 | Q9NR09 | |
| ELVLAPSEESEKYIL | 66 | Q8NI51 | |
| SIPELLRIVQIYKDL | 366 | P43652 | |
| AQSEEKLVYILPLER | 741 | Q8IUA7 | |
| YIKAVVETVDNLLRP | 616 | O94910 | |
| LEKSYELPDGQVITI | 236 | P60709 | |
| LEKSYELPDGQVITI | 236 | P63261 | |
| LAAVIEYLTAKVPEL | 56 | P0C5Y9 | |
| PILERIKAEGIIYTT | 906 | Q9UDR5 | |
| YEQELPDLTEVTLKA | 1861 | Q8TCU4 | |
| PGETKLLASEIYDIL | 96 | Q9NVT9 | |
| LSKVYEQRVPLLAVD | 1386 | Q99758 | |
| RISIYDPLKIITEDE | 51 | Q9ULD4 | |
| IVIDIPINVYKLLAE | 151 | P24530 | |
| ELPEKSKLQEIYQEL | 136 | Q9NNX6 | |
| QETKYILPTLEKELF | 101 | Q9H8G2 | |
| LLDRETLENPKYELI | 316 | P55290 | |
| LDKLQLYLPTVATDR | 511 | Q6NXP0 | |
| PVILLDEALKYLSRN | 976 | Q93084 | |
| TILEEVNYRTLPKIL | 931 | Q96MI9 | |
| ERIYLEENPEKSETI | 316 | Q9NZN5 | |
| IYLQDSVSEPLDILL | 566 | Q09MP3 | |
| DVLIVYELTPTAEQK | 2631 | P49792 | |
| LEVRSPEYTEVELKQ | 1116 | Q5T481 | |
| LYSIPIENILAVEKL | 621 | Q14644 | |
| EEVSIEVLKTYIQLL | 566 | P57740 | |
| LVAKYPSLVTEDNLL | 181 | Q17RG1 | |
| RDIKSLLDVESYNPL | 416 | Q8NAB2 | |
| KSTVVQLLERFYDPL | 1076 | P08183 | |
| IESLSRNKVLDYPAI | 351 | P28039 | |
| LSDLPVIDILKIEYI | 281 | Q9H790 | |
| TEIKELILDIKYPAT | 576 | Q9H2M9 | |
| RELYLEDSPLELKIQ | 126 | Q8TEM1 | |
| YVNVVDPKDVTLDLV | 86 | O75140 | |
| PLDRELQAVYTLSLK | 3186 | Q14517 | |
| TAILIALNKREYEIP | 666 | Q8WUM0 | |
| LIYKDEKLTVTQDLP | 56 | O95190 | |
| LEKSYELPDGQVITI | 936 | A5A3E0 | |
| SYIESLLRKEPEINI | 851 | Q8N6Y1 | |
| DQLDLVTYEEVVKLP | 721 | O14936 | |
| TEPLDKLYEVLAETL | 86 | P0C5J1 | |
| ILLKSYPEDTISEVI | 61 | Q3LI73 | |
| LSQLDPTAVYEVKLL | 581 | Q8IVU1 | |
| LLVELSLLYDQPVTS | 401 | Q9P2G4 | |
| SLRTLIPKEQKYIEE | 751 | Q6DN14 | |
| DQISIEELDIIYKVP | 251 | Q9Y295 | |
| DKLVQLYAVVSEEPI | 316 | P09769 | |
| EVLLYKLDDLTRVNP | 31 | Q96H55 | |
| KETNTDIYEVELLLP | 1101 | Q6ZRQ5 | |
| EALQLPKDLDYLTIR | 631 | Q9Y2Z2 | |
| PITLYLEKEQDKEIS | 191 | Q58FF7 | |
| LLEREIKALLTPEDY | 336 | Q9BYM8 | |
| KPTILEDLDEQIYII | 226 | Q8WVP7 | |
| VTQLLEELIVKYLPD | 531 | Q17RB8 | |
| YSIPELLTKLVQIER | 406 | Q9UNE0 | |
| IKTVYDKSVEELLPE | 96 | Q96KR4 | |
| AELLQKIEVPLYSLL | 311 | Q92598 | |
| PETVIKRLKAYEDQT | 166 | Q9UIJ7 | |
| LTLKSIQVAVEELYP | 6 | Q9C098 | |
| FSIPVIQIVYETLKD | 56 | Q92499 | |
| ANSLLVYKILEPEAL | 1796 | Q9NYQ8 | |
| LVPASDTLRKIQVEY | 1186 | O00443 | |
| VESILLTIKDDTIYL | 91 | Q02817 | |
| YIKILVEDELSSPVV | 376 | Q6P996 | |
| LLAIEDIDPTLVYIQ | 366 | Q12996 | |
| RSLYPKIIQDIETIE | 206 | Q9UKB1 | |
| IADSLEEKYTEPVIL | 3881 | Q96JB1 | |
| EEKYTEPVILNLEKT | 3886 | Q96JB1 | |
| DVLIAVEPVKTYALQ | 66 | Q01415 | |
| IINEASKVPLLAEIY | 61 | Q8TET4 | |
| QEDLRKLVTYLASVP | 71 | O60229 | |
| VTVKREPEELDQLYL | 911 | O95644 | |
| LEPSLYTVKAILILD | 6 | P61923 | |
| DLPEELLRNLYESIK | 226 | Q15438 | |
| LLYVTRPSEVEKGVL | 206 | P52848 | |
| LDNVDPAILDLIIKY | 76 | O60662 | |
| TEKLILSENYLTELP | 581 | Q96QE4 | |
| IVKTIRDIIALNPLY | 296 | P36776 | |
| LKDIEISRTPYNILS | 2496 | P24043 | |
| YLRVNPVTALTLLEK | 756 | Q9Y2D4 | |
| PNIIRLYEVVETLSK | 131 | Q8IY84 | |
| TTDLEKSLLIRYQIP | 421 | P42694 | |
| SDPDLLVQKYLEIEE | 281 | Q96M63 | |
| LLTIKEKYPQTFDDI | 1636 | Q6R327 | |
| IKVTLIETEPLAEYV | 1011 | O14522 | |
| TQIKLDPRYTADLLE | 6 | Q86UW1 | |
| TFEEVYNIILESKPE | 731 | Q9UQ26 | |
| LEKSYELPDGQVITI | 936 | Q6S8J3 | |
| EELVKPEELSKYRQV | 196 | Q9UMS4 | |
| YQEELPALLKALVSE | 226 | Q86WN1 | |
| PLVSERLELSVLYKE | 46 | Q96FW1 | |
| TVASLLKLYLRELPE | 206 | Q8N264 | |
| LKEESTLQELLLSPY | 211 | O43826 | |
| KPTAEQELYIESVIE | 531 | A4FU69 | |
| PETLDEIYNRKSVLL | 1141 | Q13315 | |
| PRQVKLLETLSEYEI | 36 | Q9P2N4 | |
| EYSEAIPILRAALKL | 321 | Q14318 | |
| LIVLLKDENTISPYE | 896 | Q9ULT8 | |
| LQEEKLIYVSERTEL | 486 | Q9BYI3 | |
| LITVPLEIDEDKYIS | 331 | Q13099 | |
| RYEIISEISKLIVPI | 1711 | Q5JSL3 | |
| ETVNEVYKLVIPILE | 1746 | Q8NF50 | |
| RVPTVVDYKEVLLTL | 406 | P41002 | |
| VDYKEVLLTLVPVEL | 411 | P41002 | |
| MQLITDIPLLDITYE | 156 | Q7RTS9 | |
| IQTEPRETLEYKAAL | 641 | Q8N960 | |
| LESIEVLKSLRYLVP | 186 | Q6P4F1 | |
| EPIEVVDLLNDLYTL | 901 | P51841 | |
| IPEILYSQIKEESGI | 181 | P51686 | |
| TLQTSLLKLELPDYV | 651 | Q9NSG2 | |
| LEKYLADLPTLDDVQ | 511 | Q5SZL2 | |
| YTIDLLLVDIKDVIL | 146 | Q9H6B9 | |
| DTLLLQENSLYTIPK | 191 | P07359 | |
| DLLTYIDDKQLTPEL | 66 | P10911 | |
| YLSPLVLRKELESLV | 1266 | O75064 | |
| DNKVLRYLAVLESPI | 416 | Q5JVL4 | |
| YRIQEKRESPEVLLT | 286 | Q14204 | |
| LLESKYPRTLDVVLE | 431 | Q9H583 | |
| ILQYLLKLPEEKEET | 1466 | Q9H583 | |
| FEPLKQTIELLKTYE | 1166 | Q9NYC9 | |
| AVAEVIKLTDPSLLY | 661 | O60645 | |
| DESYTLLVKEPVAVL | 146 | P07686 | |
| LSEEQLKEIPYTKIE | 566 | Q9HCS5 | |
| DITDIQIPLDYETEK | 31 | Q9UNP9 | |
| QRVPILLKYLDSDTE | 1491 | O43432 | |
| PLQILLEKVAATLEY | 246 | H0Y7S4 | |
| LDREKVPEYTLTIQA | 286 | P22223 | |
| QPEVVRIYISLLKES | 661 | O60716 | |
| KSQLLREIETIPYER | 1821 | A6NMZ7 | |
| LIEALLKYIETLNVP | 636 | Q08211 | |
| DVIIKETQAPAYLID | 626 | Q92845 | |
| ELQIILEKYLAVTPD | 821 | Q9BXW9 | |
| PKLLENLVVEYRTIS | 81 | Q8NGL4 | |
| LSELEEVIQYKLVPE | 1596 | P42345 | |
| LKLPSRDVTVLLENY | 551 | Q96P20 | |
| ELDKRTEYKVTLQIP | 706 | Q9NQT8 | |
| ELLPTYEIAEKQKAL | 276 | Q5TD94 | |
| SLLPTDYLVEINKIL | 1866 | P46939 | |
| LDSEYLVTLLVIVPK | 176 | Q8NEY4 | |
| LLTEEETEIPKLREY | 431 | Q68CJ6 | |
| LEVIYPQLEKGVSEL | 236 | Q6P9F5 | |
| FVTQYEPVLIESLKD | 441 | Q6NUJ1 | |
| ALPIIENYKDRLLAI | 91 | Q17R31 | |
| LTLLESDLYRKVQPS | 786 | Q07890 | |
| YTKEVLQSLPLTEII | 631 | P52630 | |
| DVIKPLQSDEYALLT | 456 | Q496J9 | |
| LRLAEIVYNIESKTP | 1701 | B5MCY1 | |
| DLPISRYKEEVVSLI | 131 | Q8NDG6 | |
| PVITKDIYEVAVSLI | 346 | Q8NDG6 | |
| LQKVVLPSYEEALSL | 231 | Q13571 | |
| PQLLSVYLEENKLTE | 116 | Q9H3W5 | |
| TLLDLNDKILDYTPQ | 86 | Q9UI40 | |
| DYLRLETLVQKVVSP | 196 | P85299 | |
| EDTLYELSLKIEPRL | 1221 | O14827 | |
| EEVPLVVYLKENAAL | 266 | Q8N3V7 | |
| TPDVAEVYLVRKNLT | 946 | Q9NTG1 | |
| DDIYKLSLVLEPRNS | 371 | Q8IV61 | |
| LLPDTITEEEKERIY | 1656 | Q96Q15 | |
| LRTLLNETPEQIKYI | 201 | O43490 | |
| AEAKIPSVIEYILDL | 706 | Q9NZC9 | |
| KTLIEYEVPQLLSSV | 701 | Q7Z3Z4 | |
| DVSSIYRVPLLLEEQ | 246 | P17812 | |
| VLTEIEYKELQLSLE | 331 | Q14190 | |
| LKEVLEYVIPELSIQ | 566 | Q9P2F8 | |
| PSSIKELTQLTELYL | 116 | Q9UQ13 | |
| IRLPSLYDLINKSVE | 376 | Q9H1N7 | |
| LEKSYELPDGQVITI | 936 | P0CG38 | |
| EVSVPLKIEYLSEEL | 1196 | Q8IZU2 | |
| ISPKLERDEVLIYNS | 1866 | P08F94 | |
| VETVQDTDLYLKSPL | 2096 | P08F94 | |
| LYDIDVAKVNTLIRP | 116 | P62750 | |
| LKELTSLVKEVYPEA | 66 | O00422 | |
| VIRDEDVIILTYPKS | 31 | Q06520 | |
| VAVLEYISADILKLV | 131 | Q07889 | |
| SYTEQELKPLTLEAL | 1296 | Q96QB1 | |
| IPLISDDIVDKLQYS | 71 | P19387 | |
| TVASLLKLYLRELPE | 226 | Q7Z5H3 | |
| YTEPVELLAVRIQLE | 231 | Q8WZ75 | |
| PILKNITDYLIEEVS | 556 | Q9BXP5 | |
| LEKYPGIQTRVLDVT | 46 | Q9BUT1 | |
| EEPTKDNLYLSIVLS | 131 | Q13733 | |
| LPEKSKLQEIYQELT | 126 | Q9H2X3 | |
| ELPEKSKLQEIYQEL | 171 | Q9H2X3 | |
| DEYKVTISPQLLLAT | 486 | Q8NE01 | |
| PDYTVRALSDLQLIK | 626 | Q8NE01 | |
| EKQYEVIIVPTLLVT | 21 | Q6J9G0 | |
| RIATDYTKEPKEQII | 2061 | O75443 | |
| LPLEEVVQEYQEIKL | 261 | Q96A61 | |
| EIIYLSENRISPLVK | 421 | Q9NR97 | |
| TITPEQLEILYEKYL | 2566 | Q86UP3 | |
| EEILRLYIDSIPKTL | 771 | Q7Z2Z1 | |
| LDENKKPVYLVTTLD | 941 | Q96RL7 | |
| LLTLEYVKAEKNVPD | 961 | Q96RL7 | |
| DNLITPVVDSLKYLT | 591 | Q8NI27 | |
| QESARIPDEYLLSLK | 21 | Q19AV6 | |
| IEAPNYLSKESEVLI | 116 | Q8TBF5 | |
| VQELYSIAIIKPDAV | 151 | Q8N427 | |
| DREAVPLTLQIIYSK | 721 | Q8WYR1 | |
| VEPDYLEVLEKQTTF | 941 | O94991 | |
| LSLLRPQIYTDLELK | 91 | Q8N2H3 | |
| LLSYNRIVKLAPEDL | 226 | Q9NR96 | |
| DISIPEYKELLQEFI | 36 | O75556 | |
| ELSLEEVLKAYEQPL | 21 | Q8WWL2 | |
| ISTLESIYQRDPLKL | 81 | P42226 | |
| LPYLVSNVIELLDVD | 86 | P17980 | |
| DLLLTALENPVKYAE | 241 | Q8IV42 | |
| LEAIYLLSPTEKSVQ | 71 | Q15833 | |
| ITTDYEILTIPVKAV | 651 | Q92545 | |
| ESLVPNALDYIRTVK | 126 | Q8WWY3 | |
| VKITYEELPAIITIE | 686 | P47989 | |
| KEVEITTTLQELLLY | 21 | Q9NZM6 | |
| ILPLLKSDLYEVIQS | 301 | P22102 | |
| YVVSPQIKEELFAIT | 916 | Q9BQI6 | |
| VKSELVPYLEKEDIQ | 656 | Q9Y2C9 | |
| TPLEELSKYVDISII | 226 | P98182 | |
| DKLLLGYSDIEIPSV | 131 | Q9HC78 | |
| IKNIEYPVDLEISKE | 701 | Q14694 | |
| TKSELLVEQYLPLTE | 181 | Q99541 | |
| LVEQYLPLTEEELEK | 186 | Q99541 | |
| EDLIYLTSDSPNILK | 181 | Q8TBZ6 | |
| PNILKELDESKAYVI | 191 | Q8TBZ6 | |
| ATSPKLLYVDRVVQE | 106 | Q9ULL1 | |
| SLKILNPEEIEKYVA | 216 | O14818 | |
| ELYRVPAKSTLLQVL | 336 | O95801 | |
| PLEVKIEEEKYTTRQ | 16 | O43309 | |
| FIQDTSLILYEEVKP | 726 | Q93009 | |
| SLILYEEVKPNLTER | 731 | Q93009 | |
| ILDPEKLTLRATYDN | 91 | Q05996 | |
| LSYDTKPEVILQLLL | 111 | Q96QT4 | |
| LYRLTVISPLDQEEI | 86 | A8MT65 | |
| TSLDLPVAIINLKEY | 56 | Q6NUM6 | |
| LTVPDYEVEDLKLLA | 566 | Q9BYX2 | |
| VVLQPYLRELLSAKD | 1096 | O95071 | |
| IESPERTDVYVEQKL | 461 | Q8NCN2 | |
| DLLQRYDSKPIVDLI | 36 | Q9Y2Y6 | |
| VYIDLTLSENKEEPV | 271 | Q15061 | |
| TRNLTYIDPDALKEL | 111 | P16473 | |
| PEEIQTVYKILAAIL | 261 | O94832 | |
| IIKILNSYTPIDDFE | 1666 | Q9NQX4 | |
| PLLLQDKVALVERYV | 176 | Q8N9H8 | |
| EDRTVPLVVEKLINY | 2071 | B2RTY4 | |
| VNDKLILPYSLSEAI | 461 | Q13459 | |
| QSIKEEKEDITYRLP | 1971 | Q13459 | |
| LPKVEILRSAIQYIE | 116 | P15173 |